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ABSTRACT 
     Delivery of gene-targeted drugs is limited by the inherently poor capacity of nucleic 
acids to overcome the membrane barrier of the cell, and development of vectors that can 
promote uptake is therefore crucial. Cell-penetrating peptides (CPPs) have emerged as 
promising vector candidates due to their ability to deliver a wide range of macromolecular 
cargos into cells. Uptake pathways of CPPs have been extensively studied for more than 
two decades, but we still lack a detailed mechanistic understanding of how CPPs interact 
with both the cell surface and the cargo to mediate delivery. 
    The work presented in this Thesis has increased our mechanistic insight into how CPPs 
function by addressing three key steps in CPP-mediated delivery: cell surface binding, stimulated 
uptake and gene delivery efficiency, using the classical CPP penetratin as a model peptide. The 
main focus is on the relative importance of the two cationic residues arginine and lysine, in 
order to rationalize the superior uptake often observed with arginine-rich CPPs. In 
addition, an important part of this Thesis is the development of a cell-like model system, 
plasma membrane vesicles (PMVs), for investigating CPP-cell surface interactions. 
     By studying both cell surface binding and internalization quantitatively, it is 
demonstrated that arginines have a greater capacity than lysines to bind to the cell surface 
and trigger internalization via macropinocytosis. Uptake efficiency is found to be dependent 
on each peptide’s cell surface affinity, rather than on specific uptake-promoting 
interactions. However, arginines are also found to be less reliant on cell surface 
proteoglycans for internalization, and thus more versatile than lysines in promoting uptake 
via multiple pathways.  
     In addition to promoting uptake, arginines are also demonstrated to be superior to 
lysines in condensing DNA and mediating gene delivery. However, arginines alone are not 
sufficient, and hydrophobic residues are found to be necessary to stabilize CPP-DNA 
interactions. To improve gene delivery further, a strategy based on cysteine modification to 
allow formation of reversible CPP dimers is assessed. It is demonstrated that 
functionalization with a single cysteine residue has the capacity to improve stability, 
enhance endosomal escape and reduce cytotoxicity of CPP-DNA complexes. Altogether, 
the work presented in this Thesis provides important implications for design of peptide-
based gene delivery vectors. 
 
KEYWORDS: Cell-penetrating peptide, Penetratin, Uptake, Stimulated endocytosis, 
Cell surface affinity, Plasma membrane vesicle, Gene delivery, Arginine, Lysine, Cysteine
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1. INTRODUCTION 
A cell is the smallest functional unit of all living organisms. It simultaneously performs 
thousands of chemical reactions, which are ultimately regulated by the genetic code 
contained in the organism’s DNA. Despite that the discovery of cells dates back more than 
three centuries [1], we are still far from a complete understanding of these remarkably 
complex entities. However, due to the rapid growth of molecular biology and genetics since 
the mid-20th century, our knowledge of cellular function has been greatly expanded down 
to the genetic level. This is also the key to understanding cellular malfunctions resulting in 
disease and, importantly, opens up the possibility to use our genome as a drug target.  
The human genome is estimated to contain approximately 25,000 protein-coding genes [2] 
and to date, mutations resulting in disease have been found in 2,700 of these genes [3]. 
Treatment for genetic disorders can in principle target either genetic or protein 
information, and both strategies involve transfer of large and complex biomolecules into 
cells; nucleic acids in the case of genetic medicines [4], and proteins in the case of protein 
therapeutics [5]. With these biopharmaceuticals, medicine is approaching a new era with 
tremendous opportunities to treat diseases in a highly specific manner that reduces the risk 
of adverse side effects. However, before actual clinical treatment the pharmaceutical 
industry must meet the challenges of poor cellular uptake, rapid degradation, and lack of 
stability commonly associated with biomacromolecules [6].  
The membrane barrier of the cell constitutes a major obstacle for gene- and protein-based 
therapies and development of vectors that can mediate cellular uptake is therefore crucial. 
This is an intense area of research and current strategies include the use of recombinant 
viruses or synthetic vectors based on lipids, cationic polymers, nanoparticles or peptides [7, 
8]. For gene delivery, viral-based vectors have completely dominated the scene, and out of 
the 1,700 clinical trials that have been approved so far, almost 70% involve the use of viral 
vectors [9]. The major advantage with viral-based vectors is their superior transfection 
efficiency compared to non-viral counterparts [10], but unacceptable side-effects have also 
raised serious concerns regarding their safety [11-13]. This clearly highlights the need for 
development of delivery vectors that are both efficient and safe. 
Cell-penetrating peptides (CPPs) are a heterogeneous class of peptides with the intriguing 
capacity to enter cells and deliver macromolecular cargos in a non-toxic manner, making 
them highly interesting as non-viral delivery vectors. Despite the fact that the first CPP 
sequences were discovered more than two decades ago [14-17], clinical trials of CPP-based 
constructs were not initiated until 15 years later. Although still in early clinical 
development, more than 20  phase I/II trials have been performed to date [18] and in 
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addition, numerous CPP-constructs for disease treatment have been described in both 
in vivo and in vitro models [19]. Despite this promising development, we still lack a detailed 
mechanistic understanding of how these peptides enter cells and deliver functional cargo. 
Today, endocytosis is recognized as a major pathway, especially when CPPs are coupled to 
large cargos, but direct penetration through the membrane is also suggested for some CPPs 
(see references [20-22] for recent reviews). A full comprehension of the molecular 
prerequisites that lead to internalization of CPPs through different routes is important for 
the future design of efficient peptide-based vectors.  
The focus of this Thesis is fundamental aspects of CPP function and the work presented in 
the appended papers aims at understanding the physico-chemical basis of membrane 
interactions, uptake and gene delivery efficiency (as outlined in Figure 1.1). At centre of 
attention is the classical CPP penetratin and its two arginine- or lysine-substituted analogs 
PenArg and PenLys, designed to investigate the relative importance of these two basic 
amino acid residues. In Papers I-III, cellular uptake of penetratin peptides is investigated and 
explanations for the differences in uptake efficiency are sought in terms of capacity to bind 
to the cell surface and to evoke a biological uptake response. Paper I explores the ability of 
these peptides to internalize into mammalian cells and trigger their own uptake by 
stimulating endocytosis. In Paper II, the relative affinity for the cell surface is investigated 
using a membrane model system that is novel in CPP research, namely plasma membrane 
vesicles (PMVs), derived directly from the plasma membrane of mammalian cells. Paper III 
addresses the role of cell surface proteoglycans in CPP uptake, by investigating the 
influence of these sulfated sugars on both cell surface binding and uptake efficiency. In 
Papers IV-V, focus is shifted from CPP interactions with membranes to interactions with 
DNA and the penetratin peptides are assessed with respect to their potential for gene 
delivery. Paper IV combines biophysical characterization of peptide-DNA complexes 
(“peptiplexes”) with transfection in live cells. Finally, Paper V explores the strategy of 
cysteine incorporation to improve peptiplex stability and endosomal escape. It is 
demonstrated throughout this Thesis that lysine-to-arginine substitution in penetratin 
results in a peptide with high capacity to bind to the cell surface, stimulate endocytic 
uptake, and mediate gene delivery, which are all key functions for an efficient cell-
penetrating peptide.  
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Figure 1.1 Overview of Papers I-V. Paper I explores uptake and endocytic stimulation, Paper II 
membrane binding affinity, Paper III the role of proteoglycans in cell surface binding and uptake, 
and Papers IV-V gene delivery efficiency of penetratin peptides. 
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2. BACKGROUND 
This Chapter provides the background and context for the research described in this Thesis. The CPP field 
is described from a historical perspective, with focus on their uptake mechanisms and their use as DNA 
delivery vectors. 
 
2.1 CELL-PENETRATING PEPTIDES 
About two decades ago, our knowledge about cell membrane impermeability was 
challenged by the discovery that certain proteins and peptides appeared to enter cells via an 
energy-independent mechanism1 [14-17]. These findings became the foundation of a new 
research field, involving the study of the uptake mechanism and applications of these 
so-called cell-penetrating peptides (CPPs), also sometimes referred to as protein transduction 
domains (PTDs). Today, more than hundred CPP sequences are known but despite this, 
CPPs as a class is still not precisely defined due to difficulties in determining their 
translocating mechanism and large variations in both sequence and secondary structure. 
The general definition today is that “CPPs are relatively short peptides, 5-40 amino acids, with an 
ability to gain access to the cell interior by means of different mechanisms, including endocytosis, and with 
the capacity to promote the intracellular delivery of covalently or non-covalently conjugated bioactive cargoes” 
[23]. Due to the lack of detailed mechanistic understanding, membrane interactions and 
uptake mechanisms of CPPs have been areas of intense investigation ever since the 
discovery of these peptides. Today, these fundamental studies are performed in parallel 
with the development of CPP-based therapeutic strategies in vivo [24]. 
2.1.1. History and Overview 
The fact that positively charged peptides can enter cells has been known since the 1960’s 
[25]. However, the real starting point for research on cell-penetrating peptides was two 
independent discoveries in 1988, showing that the 86-residue transcription-activating 
protein Tat, involved in replication of the human immunodeficiency virus HIV-1, could 
rapidly translocate over cell membranes [14, 15]. A few years later this was demonstrated 
also for the 60-residue Antennapedia homeodomain protein from Drosophila [16] and in 
1994, a 16-residue sequence from the third helix of this protein, denoted Antp43-58 or 
penetratin, was demonstrated to be responsible for its cell-penetrating properties [17]. 
Research in this area has grown rapidly ever since these initial discoveries were made, and 
                                                 
1 Since translocation was observed to occur also at 4°C and after ATP depletion. 
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more than hundred peptide sequences have been shown to enter cells and deliver 
macromolecular cargoes, including plasmid DNA, siRNA, proteins and nanoparticles, both 
in vitro and in vivo [26]. These peptides differ substantially, both with respect to their origin 
and their primary sequences, but have certain features in common, including a high content 
of positively charged and/or hydrophobic amino acid residues. CPPs have been divided 
into subgroups based on either origin (protein-derived, chimeric or synthetic) [26] or sequence 
characteristics (primary-, secondary- or non-amphipathic) [27]. Table 2.1 lists a number of 
common CPPs according to both classifications.  
Table 2.1 Classification, sequences and origin of some common CPPs and their derivatives. 
Positively charged amino acids are marked in bold and hydrophobic are underlined. 
 
Family 
 
Name Sequence† Class# 
 
Origin 
 
Protein- 
derived 
 
Penetratin (Antp43-58)* 
 
RQIKIWFQNRRMKWKK 
 
 
sa 
 
 
Drosophila homeodomain 
Antennapedia 
 Tat47-57* YGRKKRRQRRR
 
na HIV-1 protein Tat 
 pVEC LLIILRRRIRKQAHAHSK
 
sa Vascular endothelial cadherin 
     
Chimeric Transportan* GWTLNSAGYLLGKINLKALAALAKKIL 
 
pa Galanin and mastoperan 
 MPG (DeliverXTM )* GALFLGFLGAAGSTMGAWSQPKKKRKV pa Fusion sequence of HIV gp41 
and NLS of SV40 T-antigen 
 Pep-1 (ChariotTM) KETWWETWWTEWSQPKKKRKV 
 
pa Reverse transcriptase of HIV 
and NLS of SV40 T-antigen 
     
Synthetic Octaarginine (R8)* RRRRRRRR
 
na Positively charged sequence 
 MAP KLALKLALKALKAALKLA sa Amphipathic model peptide 
     
 TP10 AGYLLGKINLKALAALAKKIL pa Deletion analog of transportan 
     
 PenArg* RQIRIWFQNRRMRWRR
 
sa Penetratin analogs substituted 
with Arg/Lys 
 PenLys* KQIKIWFQNKKMKWKK
 
sa  
 EB1* LIRLWSHLIHIWFQNRRLKWKKK sa Penetratin analog designed to 
be endosomolytic  
* Peptides used in the work of this Thesis  
† From N-terminal 
# Classes of CPPs: pa; primary amphipathic, sa; secondary amphipathic, na: non-amphipathic 
 
When classified in terms of origin, the largest family is the protein-derived CPPs, which 
include the already mentioned penetratin [17] and Tat [28] peptides. Another example from 
this family is pVEC, which is an 18-residue peptide derived from the vascular endothelial 
cadherin protein, involved in cell adhesion [29]. Chimeric peptides are formed by fusing 
peptide sequences from different origins. For example, several CPPs are based on a signal 
sequence that directs insertion of intracellular proteins into the membrane of specific 
organelles, combined with a nuclear localization signal (NLS). MPG is a 27-residue peptide 
formed from the fusion sequence of HIV-1 gp41 (involved in viral fusion with the host 
cell), coupled to the NLS sequence of the Simian virus 40 (SV40) T-antigen [30]. The same 
NLS sequence combined with the HIV-1 reverse transcriptase was used to construct the 
21-residue CPP Pep-1 [31]. Both MPG and Pep-1 are today commercially available under 
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the trade names DeliverXTM and ChariotTM for in vitro delivery of siRNA and proteins, 
respectively. Another commonly used chimeric CPP is the 27-residue transportan, which 
was incidentally discovered by Langel et al. while searching for novel galanin receptors [32]. 
Transportan is a fusion peptide consisting of the neuropeptide galanin and the wasp venom 
toxin mastoparan [33]. Synthetic CPPs include both completely de novo designed sequences 
based on certain chemical traits believed to favour peptide internalization, and 
modifications of sequences with natural origin. Examples of synthetic CPPs are peptides 
designed to form amphipathic α-helices, such as the model amphipathic peptide MAP [34], 
or Tat-inspired oligoarginines [35, 36]. Other examples are a number of deletion analogs of 
transportan that have been developed to avoid the potential inhibitory effect that 
transportan exerts on membrane GTPases. Notably, transportan 10 (TP10) has been 
successful in many applications [37]. Other examples of designed CPPs include the 
penetratin analogs PenArg, PenLys and EB1. PenArg and PenLys are arginine- and lysine-
substituted penetratin versions, designed to specifically study the relative importance of 
these basic residues [38] and are central to the work described in this Thesis. EB1 
(endosomal breaker 1) was developed to avoid entrapment in endosomes following 
endocytic uptake, by formation of an α-helix that could penetrate the endosomal 
membrane upon endosome acidification [39]. CPP design is often performed on a trial-
and-error-basis, but algorithms that can predict CPP sequences based on knowledge of 
existing CPPs have also been developed and has been reviewed by Hansen et al. [40]. 
As mentioned above, CPPs can also be classified according to their amphipathic character 
and binding properties to lipid membranes, as reviewed by Ziegler [27]. Primary amphipathic 
CPPs (paCPPs) includes e.g. transportan and MPG and typically contains more than 20 
amino acids with an alternating pattern of hydrophobic and hydrophilic domains in their 
primary sequence. These peptides interact readily with both neutral and anionic lipid 
membranes. The secondary amphipathic CPPs (saCPPs), including penetratin peptides and 
pVEC, are generally shorter than paCPPs and reveal their amphipathic character first upon 
formation of α-helix or β-sheet structures that are induced by their binding to membranes. 
This class of peptides typically interact with membranes containing a certain fraction of 
anionic lipids. Non-amphipathic CPPs (naCPPs), such as Tat or R8, are generally short with a 
high or even exclusive content of cationic amino acids. This group of peptides does not 
interact with model lipid membranes unless they contain a relatively high proportion of 
anionic lipids. The sequence characteristics and membrane interactions of CPPs may to 
some extent be linked also to their uptake mechanism(s), which are further discussed in the 
following section. 
2.1.2. Mechanisms of Cell Internalization 
The mechanism(s) by which CPPs can enter cells has puzzled the CPP field for years and 
is, despite numerous studies, still not completely resolved. This is also a subject of some 
controversy, and contradictory results can be found in the literature. Our current 
understanding of CPP uptake mechanisms have been summarized in recent reviews by for 
example Madani et al. [20], Trabulo et al. [21], and Heitz et al. [22]. From a historical 
perspective, research on CPP uptake has shifted from originally being focused on finding 
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one common mechanism employed by all CPPs, towards a gradual apprehension that 
different mechanisms can be utilized depending on both CPP and cargo properties, and 
that several mechanisms are even likely to act in parallel. Given the heterogeneity in CPP 
sequence characteristics, it is perhaps not surprising that these peptides use different routes 
of entry into the cell. 
The original definition of a CPP was a peptide that could traverse biological membranes by 
a passive diffusion mechanism, independent of temperature, ATP, and receptors. CPP 
uptake was then considered as a pure physico-chemical phenomenon and peptide 
translocation was therefore extensively investigated in lipid model systems with attempts to 
explain how a charged peptide could cross a hydrophobic lipid membrane [41-50]. 
However, in 2002, the CPP field took a drastic turn when it was discovered that earlier cell 
studies on CPPs could suffer from artefacts due to redistribution of plasma membrane-
associated peptide during cell fixation and insufficient removal of externally bound peptide 
in cells analysed by flow cytometry [51, 52]. This lead to a re-evaluation of CPP uptake 
mechanisms using live cell protocols and careful removal of externally bound peptide. 
Today, endocytosis is recognized as a major pathway, especially when CPPs are coupled to 
large cargos [53-56]. Hence, CPP internalization has become more of a biological 
phenomenon that cannot be described solely by peptide-lipid interactions. Although focus 
has shifted towards endocytic mechanisms and these will most likely be involved in 
therapeutic applications of CPPs, direct translocation is still considered as a possible uptake 
route for some CPPs. Indeed, direct membrane penetration of cationic peptide segments is 
an intriguing physico-chemical phenomenon on its own and has attained considerable 
attention also outside the CPP field. The most prominent example is perhaps the 
suggestion that membrane insertion of arginine-rich domains in the KvAP K+ channel is 
decisively regulating its function [57, 58]. Both direct penetration and endocytosis can 
occur through a number of different mechanisms, which are depicted schematically in 
Figure 2.1 and will be described briefly below. 
 
Figure 2.1 Putative uptake mechanisms for CPPs.  
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Direct translocation has been proposed to occur through a number of different mechanisms, 
described by the inverted-micelle, pore formation or carpet models [20, 21]. The inverted-micelle model 
was initially described for penetratin [59] and involves destabilization of the membrane 
upon peptide binding, leading to formation of inverted hexagonal structures (micelles), 
with peptide being located in the hydrophilic environment of the micelle core. In addition 
to electrostatic interactions between positively charged CPPs and negatively charged 
membrane components, hydrophobic interactions are also suggested to be important for 
this mechanism. Pore formation can be described either by the barrel stave or toroidal models, 
which were originally presented to describe membrane interactions of anti-microbial 
peptides (reviewed in [60]). Both models involve formation of transient pores as peptides 
are inserted into the membrane and oligomerized into ring-shaped structures. In the barrel 
stave model pores are formed by amphipathic α-helical peptides, with the hydrophobic face 
interacting with the lipid chains and the hydrophilic face forming the interior of the pore. 
In the toroidal model the pores are similar, but the lipids are bent so that the peptide only 
interacts with the polar headgroups, thereby resulting in significant rearrangement of the 
lipid bilayer. The carpet model has also mainly been suggested for anti-microbial peptides [60] 
and involves accumulation of peptide at the bilayer surface and destabilization of the 
membrane in a detergent-like manner, eventually leading to membrane disruption. 
As discussed in the previous section, the amphipathic nature of a CPP has been proposed 
to influence its interactions with, and hence capacity to translocate across, the membrane 
[27]. Thermodynamic studies have shown that primary amphipathic CPPs are able to bind 
and insert into lipid membranes already at low peptide concentrations. This is suggested to 
enhance uptake via direct translocation mechanisms, but also to result in higher toxicity. By 
contrast, membrane insertion of secondary amphipathic CPPs requires a change in 
secondary structure, whereas binding of non-amphipathic CPPs occurs mainly to the 
headgroup region and membrane translocation and perturbation is therefore expected to 
take place first at elevated peptide concentrations [27]. In live cells, direct translocation has 
been observed mainly for CPPs having a high content of either hydrophobic residues [61-
63] or arginines [38, 55, 64-67]. Whereas membrane translocation of hydrophobic peptides 
is conceivable, penetration of highly charged arginine-rich peptides seems less intuitive. 
Therefore, in order to account for direct translocation of cationic CPPs, a model based on 
charge neutralization by interaction with hydrophobic counterions such as anionic lipids 
has been proposed [68-72]. In support of this model, it has been shown that cellular uptake 
of arginine-rich CPPs can be enhanced in presence of hydrophobic counterions such as 
pyrenebutyrate [73, 74]. 
Endocytosis can mechanistically be viewed upon as a two-step process where molecules are 
first internalized into lipid vesicles (termed endosomes), followed by escape from these 
endosomes and entry into the cytosol. Endocytosis consists of several mechanistically 
diverse pathways, including macropinocytosis, clathrin-mediated, caveolin-mediated and 
clathrin/caveolin-independent endocytosis, which are more thoroughly described in section 3.3.2. 
Despite the large body of literature clearly demonstrating the involvement of endocytosis in 
CPP uptake, the contribution from each pathway remains elusive and one predominant 
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mechanism is unlikely to be established. Instead, different routes of entry, both endocytic 
and non-endocytic, appears to be utilized depending on the nature of both the CPP 
(sequence, conformation, length) and the cargo (type, size, binding methodology), but also 
on experimental conditions such as cell type and peptide concentration with respect to cell 
density [20, 22]. 
To understand CPP uptake from a mechanistic perspective, much effort has been put into 
identifying cell surface binding sites that could act as mediators of CPP internalization. Due 
to their positive charge, CPPs interact electrostatically with a variety of cell surface anions, 
including different proteins, lipids and sugars. However, few of these molecules have been 
systematically investigated in the context of CPP uptake, and most focus has been on cell 
surface proteoglycans (PGs), especially those containing heparan sulfates (HSPGs). These 
glycoproteins are heavily substituted with sulfated carbohydrates, and thus possess a high 
negative charge density (described in section 3.3.1.). In addition to their polyanionic nature 
that facilitates binding through electrostatic attraction, HSPGs are known to be involved in 
endocytosis of protein ligands [75, 76]. It has also been suggested that cationic CPPs may 
induce clustering of HSPG chains at the cell surface, resulting in initiation of intracellular 
signalling cascades that trigger endocytosis [76, 77]. However, such clustering events have 
only been observed in vitro in bulk experiments with soluble sulfated sugars [78-81]. 
Comparative studies of CPP uptake in wild-type and PG-deficient cells are frequently 
encountered in the literature. CPP uptake is, in general, significantly reduced but not 
completely abolished in the absence of PGs [55, 82-89]. Most of these studies have focused 
on oligoarginines or else arginine-rich peptides such as Tat, but PGs have also been shown 
to promote uptake of the hydrophobic transportan analog TP10 [89], and are suggested to 
be involved in uptake of MPG [90]. However, despite seemingly compelling evidence that 
PGs are involved in internalization of CPPs, their exact role in mediating uptake is still 
elusive. Clearly, the negative charge of these sulfated sugars provides unspecific 
electrostatic attraction for cationic CPPs, but in addition, a more specific receptor-like role 
has been suggested, as certain CPPs bind selectively to proteoglycans with particular 
patterns of sulfation [76, 77, 84, 91-94]. On the other hand, recent studies have pointed 
towards that proteoglycans may in fact have a less prominent role in uptake of 
oligoarginines [95] and cargo transduction of Tat [86], and for Tat the role of membrane 
proteins was instead emphasized. 
Twenty years of research has certainly expanded our knowledge of CPP uptake, but has 
also made its complexity increasingly clear. Today, we still lack definite answers to several 
key questions, including how different physico-chemical properties of CPPs determine 
their corresponding uptake pathway(s) (i.e. clear structure-activity relationships), what 
interactions on the cell surface that elicit an uptake response, and how CPPs escape across 
endosomes and deliver functional cargo. The fact that these important pieces of the puzzle 
are still missing limits the successful development of CPPs as intracellular delivery vectors. 
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2.1.3. Penetratin Peptides 
The classical CPP penetratin and its two arginine- or lysine-substituted analogs PenArg and 
PenLys, have been used throughout the work presented in this Thesis. Earlier studies with 
these peptides are therefore summarized below. Recent literature reviews of membrane 
interactions, uptake mechanisms and cargo delivery of penetratin can also be found in work 
by Dupont et al. [96, 97] and Alves et al. [98]. 
As previously mentioned, penetratin was one of the first CPPs to be discovered. This 
16-residue peptide is derived from the Drosophila Antennapedia protein, which belongs to a 
group of transcription factors called homeoproteins. These proteins regulate transcription 
by binding to DNA via a highly conserved motif called the homeodomain. DNA binding 
involves three α-helices, with the third helix being responsible for recognition and binding 
to the DNA major groove [99]. It was also this helix that was found to mediate 
translocation of the Antennapedia protein [17]. Penetratin was originally reported to enter 
cells by an energy-independent pathway, with tryptophans suggested to be critical for the 
translocation process [17]. Further studies concluded that uptake was independent of both 
chiral membrane receptors and α-helical structure, since D-analogs, inversed or scrambled 
sequences, and penetratin versions substituted with proline residues to break α-helicity, 
were all efficiently internalized [59]. A direct translocation mechanism based on formation 
of inverted micelles was proposed [59] and found some support from nuclear magnetic 
resonance (NMR) studies showing that interaction of penetratin with membranes can result 
in formation of inverted structures [100]. Several structure-activity relationship (SAR) 
studies have clearly demonstrated that basic residues are critical for uptake of penetratin 
[38, 101-103]. The importance of hydrophobic residues, in particular the two tryptophans, 
is less clear, and SAR studies both support [103] and reject [38] their involvement in 
penetratin uptake.  
 
Figure 2.2 Structure of penetratin when bound to lipid membranes. The molecular 
coordinates are adapted from the 1OMQ structure in the Protein Data Bank, deposited by 
Lindberg et al. [44]. Helical wheel representation with basic residues depicted in grey is shown to 
the right. 
In order to obtain a physico-chemical explanation for its membrane translocative 
properties, penetratin has been extensively studied in lipid model systems. Penetratin 
interacts readily with anionic lipid membranes and binds with a parallel orientation to the 
membrane surface with only limited bilayer insertion [43-45, 102]. In addition, membrane 
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binding leads to a structure transformation from random coil to an amphipathic α-helix 
(Figure 2.2) [43, 44, 102-106], but penetratin also appears to possess conformational 
plasticity which allows it to transform to β-sheets at higher peptide/lipid ratios [104, 105]. 
Interestingly, this secondary structure was recently reported to be predominant in 
cells [107]. Despite these observations, ordered secondary structure content does not seem 
to promote uptake. By contrast, even a negative correlation between α-helical content and 
internalization efficiency has been proposed [43]. Translocation of penetratin across lipid 
bilayers has also been investigated in different lipid model systems. The first direct 
observations of penetratin translocation was reported in 2000, using fluorescence 
microscopy to explore internalization into giant unilamellar vesicles (GUVs) [50]. Since 
then, several conflicting results have been reported [41, 46, 49], but translocation has also 
been observed in the presence of a transmembrane potential [42, 48]. The ability of 
penetratin to translocate across a pure lipid bilayer thus appears to be dependent on model 
system. 
As described in the previous section, CPP research has today shifted focus from direct 
translocation mechanisms towards endocytosis, following the discoveries of potential 
artefacts in earlier work [51, 52]. For penetratin, the initial reports on direct translocation 
has also been re-evaluated but since live cell studies have both confirmed [38, 108] and 
rejected [88, 109] involvement of direct translocation the matter remains unresolved. 
Membrane translocation has been suggested to exclusively occur within limited 
concentration regimes, but also here the reports are incoherent, with translocation 
observed either at low [88, 110] or high penetratin concentrations [55]. However, although 
direct translocation may still contribute to penetratin uptake, a vast number of live cell 
studies today point towards different endocytic pathways as major uptake routes for 
penetratin [38, 55, 108]. In addition, involvement of proteoglycans has been suggested in 
several studies [83, 88, 89, 110] and penetratin have also been shown to cluster such 
sulfated sugars in vitro [79, 81]. In summary, it thus seems like penetratin can use different 
routes of entry into cells, even though we still lack a complete mechanistic understanding 
of this process. Nevertheless, penetratin has been shown to enter cells even when coupled 
to macromolecular cargos and has been successfully used for delivery of e.g. peptides, 
proteins, oligonucleotides and siRNA (see ref. [97] for a comprehensive review). Today, 
penetratin is also commercially available with an N-terminal pyridyl disulfide function, 
allowing conjugation via disulfide bridges to cargos carrying thiol groups (e.g. cysteine 
residues) [111]. 
In 2003, our group expanded the penetratin family with two new members [38]; the 
arginine- or lysine-substituted analogs PenArg and PenLys (Figure 2.3). It had previously 
been shown that arginines were fundamentally important for the function of Tat and 
furthermore that oligoarginines could enter cells more efficiently than oligolysines [35, 64]. 
With PenArg and PenLys, the arginine versus lysine comparison was extended also to 
penetratin, which compared to Tat normally has a higher lysine-to-arginine ratio and, in 
addition to positive charge, also contains hydrophobic residues. A live cell study involving 
this penetratin triplet of peptides indicated that arginine substitution promotes endocytic 
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uptake into cells and also provides a certain ability to enter cells through non-endocytic 
routes [38]. Lysine substitution initially appeared to completely abolish uptake [38], but the 
extensive characterization described in this Thesis shows that PenLys is actually weakly 
internalized (section 5.1.). The penetratin peptides have also been thoroughly investigated 
in lipid model systems in order to explain the large dissimilarities in cellular uptake from a 
physico-chemical perspective. Arginine/lysine-substitution creates a penetratin peptide 
with similar structure, orientation and insertion depth into lipid bilayers [43], but arginines 
do enhance binding affinity for anionic membranes [43, 47], and counterion-mediated 
partitioning into a hydrophobic phase [68]. A higher capacity to cause local lipid 
rearrangement has also been suggested [43]. However, these differences are not large 
enough to account for the accentuated differences in peptide internalization into cells, and 
the focus of this Thesis is therefore to search for explanations for the superior uptake 
capacity of arginines on a molecular level. 
 
Figure 2.3 Amino acid sequences of penetratin peptides. Arginines are marked in red, lysines 
in green and hydrophobic residues in blue. 
2.1.4. CPP-Mediated Delivery of Nucleic Acids 
Nucleic acids are promising drug candidates due to their ability to specifically target disease 
at the genetic level. However, successful pharmacological application of these molecules is 
highly dependent on development of non-toxic delivery vectors that can provide efficient 
protection from degradation and promote both internalization into target cells and 
subsequent release in the cytoplasm or nucleus. Nucleic acid-based strategies include both 
short sequences such as small interfering RNAs (siRNAs) and antisense oligonucleotides 
(ONs) that interfere with gene expression by targeting mRNA in the cytoplasm, and 
plasmid DNA containing thousands of basepairs for delivery into the cell nucleus and 
expression of therapeutic genes [21, 22].  
CPPs have been successfully used to deliver nucleic acid cargos [112, 113]. Most of these 
applications have involved delivery of short oligonucleotides, and relatively few have 
reported delivery of entire plasmids. In early studies, the most common approach was to 
covalently attach cargo to the CPP through various linkers, but in recent years 
non-covalent strategies based on condensation of DNA through electrostatic interactions 
have gained attention due to the relative ease and higher versatility associated with this 
method. In addition, while covalent CPP technology provides high reproducibility and 
control of the stoichiometry of the CPP-cargo constructs, a major limitation with this 
approach appears to be the risk of altering the biological activity of the cargo [22]. Covalent 
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strategies have been used for neutral oligonucleotides such as peptide nucleic acids (PNAs) 
[114-116]. However, non-covalent complex formation with peptide in excess may be more 
promising for negatively charged cargos such as siRNA, since the negative charges 
otherwise mask the cationic peptide charges and thus perturb CPP function [117]. In 
addition, non-covalent attachment is essentially a requirement for delivery of plasmid 
DNA, due to the large size and high number of negative charges [112]. 
The first CPP to be extensively explored for non-covalent delivery was the chimeric 
peptide MPG. It has been used in this way to deliver both oligonucleotides [30, 61] and 
plasmid DNA [118]. Non-covalent approaches have been extended also to other CPPs, but 
the main limitations for efficient delivery appear to be lack of peptiplex stability and 
entrapment of cargo in endocytic vesicles. Different strategies to avoid these limitations 
have therefore been investigated in many studies. For Tat, the transfection efficiency has 
for example been shown to be enhanced by formation of multimers or branched Tat 
variants [119-121], most likely due to an improved capacity to condense DNA. In addition, 
incorporation of hydrophobic groups such as stearyl chains increase delivery of both 
plasmids and oligonucleotides using oligoarginines [122-124], and oligonucleotide delivery 
with the transportan analog TP10 [125]. This approach has been suggested to stabilize 
peptiplexes and improve membrane interactions to facilitate both uptake and endosomal 
escape [122, 123]. Another strategy involves incorporation of an endosome-disruptive 
sequence, which has been shown to enhance penetratin-mediated delivery of siRNA [39]. 
An alternative interesting approach to CPP-mediated gene delivery involves combination 
of CPPs with other gene delivery methods such as liposomes, polyethyleneimine or 
nanoparticles, in order to combine efficient packaging, delivery and targeting [21]. One of 
the most sophisticated systems is the so-called Multifunctional Envelope-type Nano 
Devices (MEND), which are virus-inspired assemblies consisting of a polycation-
condensed DNA core, coated with a lipid envelope functionalized with octaarginines [126, 
127]. 
In summary, a vast number of reports have clearly demonstrated the potential of cell-
penetrating peptides as delivery vectors for therapeutic biomolecules such as nucleic acids. 
Today, several pre-clinical and clinical trials are already underway [18, 22], even though we 
still lack detailed mechanistic insight to several fundamental questions regarding CPP 
function. The work presented in this Thesis aims at answering some of these questions, by 
exploring the effect of amino acid substitution on membrane interactions, uptake pathways 
and cargo delivery capacity of CPPs. Combining such mechanistic studies with continued 
efforts to reach clinical trials will hopefully make way for therapeutic use of cell-penetrating 
peptides. 
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3. FUNDAMENTAL CONCEPTS 
This Chapter describes the fundamentals of biological macromolecules and cellular membranes, important 
for the work in this Thesis 
 
3.1. PEPTIDES 
Peptides are the central molecules in this Thesis, and this section aims at describing the 
structure and function of these biopolymers from a general perspective. Peptides and 
proteins (i.e. polypeptides) have the dual role of being both main building blocks and working 
machinery of living cells, executing nearly all cellular functions. This functional heterogeneity 
implies a chemical and structural diversity and this is provided by the sequence of amino 
acid building blocks.  
The general structure of an amino acid, with a so called α carbon being attached to an 
amino group, a carboxyl group and a side chain (R), is shown in Figure 3.1A. In the 
physiological pH range, both the carboxyl and the amino group will be charged and the 
amino acid is thus a zwitterion. Amino acids in peptides and proteins are covalently linked 
together through formation of an amide bond between the carboxyl and amino groups of 
two adjacent amino acids. The unreacted amino and carboxyl groups at each end are called 
N- and C-terminus respectively. Many proteins have N-termini blocked with an acetyl 
group and a few also have C-termini modified to amides [128]. Such modifications are also 
common in synthesis of peptides, to avoid contributions from terminal charges. A peptide 
sequence is commonly reported by its one- or three-letter amino acid abbreviations, written 
with the N-terminus to the left and C-terminus to the right.  
The amide bond, or more commonly peptide bond, has substantial double bond character 
and as a consequence, the O, C, N and H atoms are essentially coplanar, i.e. lie in the same 
geometric plane. Polypeptides usually fold into regular secondary structures, out of which the 
most common are the right-handed α-helix and the parallel or anti-parallel β-sheet. Peptide 
regions with less defined structures are collectively denoted as random coils. The secondary 
structures of proteins are commonly studied by X-ray crystallography or nuclear magnetic 
resonance (NMR), but can also be measured using spectroscopic techniques. Circular 
dichroism (see section 4.1.3.) is for example a standard technique for determination of 
secondary structure content of soluble proteins and also for monitoring conformational 
changes such as folding/unfolding reactions. 
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Figure 3.1 Structure of α amino acids. (A) General backbone structure and formation of 
zwitterion. (B) Structure of side chains relevant for the work of this Thesis. Note that the positive 
charge of arginine is delocalized over the three nitrogens. 
As mentioned above, the properties and structure of peptides and proteins are depicted by 
their amino acid sequence. The amino acid alphabet contains 20 different letters, all with 
different side chain composition and thus different chemical properties. Based on the 
nature of the side chain, amino acids are divided into acidic, basic, polar or hydrophobic. 
A few amino acids are of particular importance for the work in this Thesis and that is first 
of all the basic amino acids arginine (R) and lysine (K), which are two of the most common 
residues found in CPP sequences and have been shown to be decisive for their function 
[35, 101, 103, 129]. These both contain ionisable nitrogen-containing groups, amine in the 
case of lysine and guanidinium in the case of arginine (Figure 3.1B). With pKa values above 
9, these side chains are positively charged at physiological pH. Arginines and lysines thus 
carry identical charge and have only minor differences in chemical structure. Yet, the 
guanidinium group of arginine side chains have the ability to form particularly stable 
bidentate hydrogen bonds with oxo-anions such as phosphates or sulfates and 
consequently, arginines have been suggested to possess an enhanced capacity to interact 
with these biomolecules, compared to lysines [130]. The amino acid alphabet contains also 
a third basic residue, namely histidine (H), but since it has a pKa around 6, histidine is only 
positively charged in acidic environments. 
A second class of amino acids that has attracted some particular attention in CPP research 
are the aromatic amino acids, phenylalanine (F), tyrosine (Y) and tryptophan (W). Due to 
their conjugated rings, these residues all have hydrophobic character and furthermore 
absorb and emit light in the UV region, making them possible to study by optical 
spectroscopic techniques (see section 4.1.). Tryptohan has become the primary chromophore 
in spectroscopic studies of proteins and peptides due to its environment-sensitive 
photophysical properties. Tryptophan emission is sensitive to solvent polarity and thus 
functions as an intrinsic reporter of environmental changes that can be used to study e.g. 
protein folding or peptide-membrane binding (see reference [131] for examples). 
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Tryptophan is also interesting since it has been suggested to be involved in mediating 
uptake of CPPs [17, 101, 103]. 
The last amino acid that plays a role in the work of this Thesis is cysteine (C). The side chain 
of cysteine contains a thiol (SH) group that can form a disulfide bridge with another cysteine 
side chain through oxidation. These bonds play an important role in folding and stability of 
proteins and are further utilized in Paper V of this Thesis to form CPP dimers. 
3.2. DNA 
DNA is a nucleic acid and thus belongs to another major class of biomacromolecules. 
Nucleic acids perform the fundamental task of storing and transmitting genetic information 
and can thus be regarded as the most central molecules for life itself. Indeed, the discovery 
of the molecular structure of DNA was awarded the Nobel Prize in 1962 [132]. In this 
Thesis, the role of DNA is as a cargo molecule, i.e. DNA is used to investigate the capacity 
of CPPs to deliver macromolecules into cells. This section will present the basic structure 
and function of DNA and further describe condensation of DNA for gene delivery 
purposes.  
There are two types of nucleic acids, ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). 
They both consist of a polymeric chain, built up from monomeric units called nucleotides, 
connected by covalent bonds. In DNA, the nucleotides in turn consist of a five-carbon 
sugar (deoxyribose), a negatively charged phosphate group and one of four possible nitrogen 
bases: adenine (A), thymine (T), cytosine (C), or guanine (G) (Figure 3.2A). While 
alternating sugars and phosphates are structural components forming the DNA backbone, 
the bases hold the genetic code, i.e. they contain the information needed to make and maintain 
a living organism. The key to this intriguing property is the ability to perform self-duplication. 
This is in turn due to the specific base-pairing, i.e. formation of hydrogen bonds, between A 
and T or C and G respectively. However, to describe the molecular basis for DNA 
function, the basic structure of the DNA molecule first needs to be considered.  
Under physiological conditions, DNA exists as a double-stranded, right-handed helix with 
two identical, but anti-parallel strands (Figure 3.2B). While the hydrophilic and highly 
negatively charged sugar-phosphate backbone faces the aqueous surroundings, the bases 
are directed towards the centre of the helix, perpendicular to the helix axis. This 
configuration also gives rise to two spiral grooves, the wide major groove and the narrow 
minor groove. The helical structure is stabilized by hydrophobic interactions between the 
stacked bases and by hydrogen bonding between bases on opposite strands. Due to the 
hydrogen bonding pattern of the four bases, this base-pairing is highly specific, which 
implies that the two strands are complementary to one another. This is also the key to the 
self-replicating property of DNA that is used both to copy the genome during cell division 
(i.e. replication), and to produce complementary single-stranded RNA molecules that can 
subsequently be used as templates to direct protein production (i.e. transcription and 
translation). These fundamental processes are together known as the central dogma of 
molecular biology [133]. 
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Figure 3.2 Structure of DNA. (A) The four DNA bases (B) The DNA double helix. 
3.2.1. DNA Condensation for Gene Delivery 
Condensation of DNA is of vital importance in vivo. The most striking example is 
packaging of the genome into chromosomes, where approximately 2 m of DNA is 
confined to a µm-sized cell nucleus. A similar decrease in DNA volume can be obtained 
also in vitro using chemical agents, e.g. for gene delivery purposes. DNA condensation in 
vitro is a large research field on its own and is not a major focus of this Thesis, but the 
basics of this process will be briefly described below as they are of importance for the work 
presented in Papers IV and V. 
In aqueous solution, DNA exists as a random coil due to repulsion between the negative 
charges in the phosphate backbone. Hence, efficient transport of DNA over the 
hydrophobic plasma membrane (section 3.3.) requires reduction of both size and charge. 
During condensation of DNA, the random coil structure is transformed to a state where the 
volume fraction of DNA and solvent are comparable and the helices might be separated by 
only a few layers of water. Although condensation of single molecules has been observed, 
usually several DNA molecules are incorporated into the same particle. It can thus be 
difficult to clearly distinguish condensation from aggregation, but the term condensation is 
often defined as formation of aggregates with a finite size and ordered morphology [134, 
135]. 
Many different substances can be used for condensation of DNA and in all cases, 
condensation is achieved either by decreasing the repulsion between the DNA segments or 
by making DNA-solvent interactions less favourable. Charge neutralization of the 
phosphate backbone can for example be achieved by cations, whereas solvent interactions 
can be perturbed by adding a poorer DNA solvent or a polymer that excludes volume and 
results in molecular crowding. Additionally, multivalent cations may also facilitate 
condensation by causing local distortion or bending of the helix structure [135]. 
Condensation of DNA is a result of a rather complex interplay between different 
interactions, including the electrostatic forces between DNA and its counterions or 
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different DNA segments, entropy loss upon collapse into an ordered state, entropy gain 
from released counterions, and bending stiffness of the helix that limits the maximum 
curvature [134]. 
3.3. THE MEMBRANE BARRIER  
Biological membranes constitute a major obstacle for intracellular delivery vectors such as 
CPPs and interaction with and uptake over the plasma membrane is the main focus of this 
Thesis. This section presents the basic structure and function of biological membranes, 
describes mechanisms for transport over the membrane and finally discusses the use of 
membrane models to study membrane interactions. 
3.3.1. Cellular Membranes 
Cells are enclosed by a plasma membrane that serves as a protective barrier and maintains the 
essential differences between the cell interior (cytosol) and the extracellular milieu. In 
eukaryotic cells, membranes are also used for compartmentalization by separating 
membrane-enclosed organelles such as the nucleus, mitochondria, endoplasmatic reticulum 
(ER), and Golgi apparatus from the cytosolic environment. The exact membrane 
composition can vary significantly with cell and organelle function, but all membranes have 
a common structure that can be described as a thin film of phospholipids and protein 
molecules, held together mainly by non-covalent interactions. Lipids, out of which 
phospholipids are the most abundant type, form the matrix of membranes and typically 
constitute 50 mass percent of animal cell membranes [136]. The amphipathic nature of 
phospholipids, with polar head groups and hydrophobic hydrocarbon tails, results in that 
lipids are highly prone to self-associate into energetically favoured bilayers, where the 
hydrophobic tails are sandwiched between the hydrophilic heads and thus shielded from 
water (Figure 3.3). Apart from phospholipids, the membrane also consists of varying 
amounts of sterols, with cholesterol being the major sterol component in mammalian cells. 
Cholesterol has a structure consisting of four rigid rings, which partly immobilizes the 
hydrocarbon tails and therefore reduces membrane permeability. Membrane proteins are 
embedded into the lipid matrix either as peripheral or membrane-spanning and perform 
most of the specific functions of cell membranes, such as cell signalling and membrane 
transport. 
 
Figure 3.3 Schematic illustration of phospholipid structure, bilayer formation and 
membrane organization. 
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The cell membrane may contain hundreds of different lipid species, entailing its structural 
and functional complexity [137, 138]. Originally, the lipid portion of the membrane was 
described as a continuous fluid phase, in which membrane proteins are randomly dispersed 
(the fluid mosaic model from 1972 [139]). However, during the last decades it has become 
increasingly clear that the lateral motion of membrane components is more restricted, and 
that membranes may contain regions of variable thickness and with accumulation of certain 
lipids and proteins [140, 141]. These microdomains, or lipid rafts, enriched in sphingolipids, 
cholesterol and particular proteins have gained considerable interest for their possible 
function in cell signalling and regulation [142, 143], and have also been suggested to be 
involved in uptake of CPPs [144]. The lipid bilayer is not merely a passive barrier, but in 
addition to its protective role lipids take an active part in cell function, e.g. by enabling 
membranes to change shape and thereby perform budding, tubulation, fusion and fission 
and, furthermore, as first and second messengers in signal transduction [137, 138]. 
The plasma membrane is not only laterally segregated, the distribution of membrane 
components between the intra- and extracellular leaflets is also asymmetric. This 
asymmetry is functionally important, since many cytosolic and extracellular proteins or 
ligands bind specifically to certain lipid headgroups [145]. In eukaryotic plasma membranes, 
anionic lipids such as phosphatidylserine (PS) and phosphatidylinositol (PI), are mainly 
distributed in the inner leaflet, while e.g. sphingomyelin and sugar-containing glycolipids are 
exposed to the extracellular environment [138, 146]. Lipid asymmetry is not static, and loss 
of lipid asymmetry to expose PS in the outer leaflet can for example be triggered by 
external stimuli and is an early marker for apoptosis [147]. 
In addition to lipids and proteins, the cell surface is also rich in sugars, out of which many 
are negatively charged. These oligosaccharides are covalently attached to both lipids 
(glycolipids) and proteins (glycoproteins) and together form a carbohydrate coat on the 
membrane called the glycocalyx. A group of glycoproteins that has received particular 
interest in CPP research are the proteoglycans (PGs), which have been suggested to have a 
receptor role in uptake [76, 77]. They are distinguished from other glycoproteins by the 
nature, arrangement and quantity of sugar chains. First of all, PGs must by definition 
contain at least one glycosaminoglycan (GAG) chain. GAGs are built up from chains of 
alternating amino sugars and uronic acids that are highly sulfated and also contain carboxyl 
groups. This makes GAGs the most anionic molecules produced by animal cells and due to 
this polyanionic nature they have, from a physico-chemical perspective, been described as 
an extracellular equivalent to DNA [76]. In contrast to the short, branched oligosaccharides 
found on most glycoproteins, GAGs are long (typically 80 residues) and unbranched. 
Proteoglycans are heavily glycosylated with up to 95 mass percent carbohydrates attached 
to a core protein, that is either inserted across the bilayer or coupled to a 
glycosylphosphatidylinositol (GPI) anchor. PGs as a group possess almost limitless 
diversity due to different core proteins, variations in number and type of attached GAG 
chains and also the pattern of sulfation of these chains. 
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Proteoglycans are not only diverse in terms of structure, but also in terms of function and 
their physiological importance is illustrated by the severe developmental defects that may 
occur when inactivated by mutation [76, 77, 148]. Cell surface proteoglycans are known to 
work as binding sites for numerous protein ligands, often acting as co-receptors that 
promote interaction with conventional receptor proteins [136, 148, 149]. One subclass of 
proteoglycans that has received particular attention for their receptor roles are the heparan 
sulfate proteoglycans (HSPGs), containing the GAG heparan sulfate (HS) (Figure 3.4). HS 
consists of disaccharides units (~ 10-50) built up from N-acetylglucosamine (GlcNAc) and 
glucuronic (GlcA) or in some cases iduronic (IdoA) acid, that are all modified by sulfate 
groups at different positions. HSPGs are in turn divided into two main families: GPI-
anchored glypicans and transmembrane syndecans. Glypicans have HS chains attached close to 
the cell membrane and play a crucial role in development and morphogenesis. Syndecans 
instead display HS chains at their distal ends and function in growth factor regulation and 
cell adhesion. Certain proteins have binding motifs containing patterns of charged residues 
that are suggested to promote binding to HS [76, 77]. In addition, HSPGs have been 
proposed to have a receptor function in uptake of cationic peptides such as CPPs. 
However, the exact role of HSPGs in CPP uptake is not clear, which is further discussed in 
section 2.1.2. In biophysical studies of interactions with sulfated sugars, heparin is often 
used as a mimic for cell surface HS. Heparin and HS differ to some extent in their 
saccharide units (iduronic acid instead of glucuronic acid in heparin) and degree of 
sulfation, with heparin being more highly sulfated. 
 
Figure 3.4 Schematic overview of heparan sulfate proteoglycans (HSPGs). Left: Chemical 
composition. Right: Membrane organization. 
3.3.2. Endocytosis 
The plasma membrane serves as a selective barrier that efficiently prevents transport of 
large and polar molecules, whereas small and hydrophobic molecules can permeate the 
membrane by passive diffusion. However, most molecules bypass direct membrane 
transport by using highly regulated processes. These are performed by designated 
membrane transporter proteins that either act as carriers or channels through the 
membrane, or as receptors for initiation of endocytosis. Endocytosis is a general term for 
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several diverse processes in which the cell instead internalizes macromolecules through the 
formation of membrane vesicles. As discussed in section 2.1.2., it is also considered to be a 
major route of entry for CPPs. 
During endocytosis, extracellular material becomes enclosed into membrane vesicles called 
endosomes that pinch off from the plasma membrane on the intracellular side. Once inside 
the cell, endosomes undergo a maturation process from “early” to “late” endosomes. The 
maturation is accompanied by acidification, gradually lowering the endosomal pH. If not 
retrieved from the endosomes, the endocytosed material will end up in lysosomal 
compartments, the principal sites of intracellular digestion, which are rich in degrading 
enzymes such as acid hydrolases. 
Endocytosis can be divided into two main categories: phagocytosis (“cell eating”) or 
pinocytosis (“cell drinking”). Phagocytosis is a receptor-mediated process performed by 
specialized cells in the immune system and involves engulfment of large particles by actin-
driven protrusions. Pinocytosis, on the other hand, is performed by essentially all cell types 
and can occur via several different pathways including macropinocytosis, clathrin-mediated 
endocytosis, caveolin-mediated endocytosis and clathrin- and caveolin-independent 
endocytosis (Figure 3.5). The pinocytic rate differs between cell types, but typically ~1% of 
the membrane is ingested each minute [136]. 
 
Figure 3.5 Schematic illustration of different pinocytosis mechanisms. 
Macropinocytosis differs mechanistically from other endocytic processes in the way the 
vesicles are formed. Whereas pinocytosis is normally initiated at sites of plasma membrane 
invagination, macropinocytosis occurs at locations of membrane protrusion, driven by 
actin polymerization. These protrusions collapse back and fuse with the membrane, 
encapsulating and internalizing both membrane-bound material and extracellular fluid. The 
vesicles that are formed are irregular in shape and large (typically 1-5 μm in diameter) 
compared to other endosomes (~100 nm). Macropinocytosis is most common at specific 
membrane sites where the cells are continuously creating waves of actin protrusions, a 
process called cell surface ruffling. In most cells, macropinocytosis levels are intrinsically low, 
but they can be transiently induced by growth factors and other external stimuli. Triggering 
of macropinocytosis involves activation of receptor tyrosine kinases, resulting in signalling 
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cascades including the Rho family of GTPases, acting in concert with phosphoinositide 
3-kinase (PI(3)K) to initiate actin polymerization and macropinosome closure [150, 151]. 
While the exact role(s) of macropinocytosis remains somewhat elusive, it has emerged as a 
key mechanism for delivery of a range of macromolecules [150], including cell-penetrating 
peptides [152], making this pathway particularly interesting from a drug delivery point of 
view. In addition, macropinosomes have intriguingly been observed to remain isolated 
from the endolysosomal system, indicating a distinct pathway with possible potential to 
escape endosomal degradation [153].  
As mentioned above, other endocytic mechanisms involve invaginations of the plasma 
membrane that eventually bud off to form endosomes. In the case of clathrin-mediated 
endocytosis (CME), membrane deformation is aided by a protein network and the endosome 
is pinched off by the GTPase dynamin, which assemble as a ring around the neck of each 
bud. Clathrin-coated vesicles also provide an efficient uptake pathway for selective 
receptor-mediated endocytosis, where specific macromolecules bind to cell-surface 
receptors prior to internalization. Caveolae-mediated endocytosis is instead initiated at flask-
shaped invaginations in the plasma membrane called caveolae, which are formed at 
membrane domains rich in cholesterol and sphingolipids [154]. The shape of the caveolae 
is conferred by the cholesterol-binding protein caveolin that forms a coat on the surface of 
the membrane invaginations. In addition, a number of less well-defined endocytic 
mechanisms that are seemingly independent of both clathrin and caveolin also exist. The 
different endocytic mechanisms are thoroughly described in the review by Conner and 
Schmid [155] and their importance for CPP internalization is discussed in section 2.1.2. 
3.3.3. Model Membranes 
From the description of biological membranes above, it stands clear that these are 
remarkably complex in both structure and composition. Due to difficulties in adapting 
cellular membranes to most biophysical techniques, more simplified model systems in the 
form of planar lipid bilayers or spherical vesicles called liposomes are often used to investigate 
membrane interactions [156]. Despite that they lack proteins and carbohydrates, these 
model systems have been enormously valuable in studying lipid interactions at a molecular 
level. The choice of model system is directly dependent on the type of experiment. While 
planar bilayers are used with techniques such as Atomic Force Microscopy (AFM), Quartz 
Crystal Microbalance (QCM), or solid state Nuclear Magnetic Resonance (NMR), vesicles 
are often used to study interactions in solution by different spectroscopic techniques or by 
microscopy.  
The membrane models described above constitute well-defined systems, making it possible 
to explore particular interactions in detail. However, the main limitation is that these 
simplified systems sometimes lack sufficient similarity with actual cell membranes, making 
it difficult to draw conclusions that are valid in a biological context. This has become a 
particular concern in CPP research, since it has indeed been difficult to find robust 
correlations between interactions with model lipid membranes and uptake in live cells [43, 
47, 157]. Therefore, in this Thesis, a membrane model that is more representative of the 
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plasma membrane is explored to assess cell surface association of CPPs as opposed to lipid 
bilayer interaction. Plasma Membrane Vesicles (PMVs) is a novel model system in CPP 
research, but have previously been used for a number of different applications including 
studies of membrane phase separation [158], lateral diffusion by membrane proteins [159], 
lipid-protein interactions [160], membrane protein proteomics [161], and as a membrane 
source for nanotechnological applications [162].  
Development of PMVs is based on a discovery made more than 30 years ago, when it was 
found that cells can release micrometer-sized vesicles upon exposure to formaldehyde (FA) 
and dithiothreitol (DTT) [163-165]. Since then, the formation mechanism, often referred to 
as blebbing, has been investigated to some degree and it is believed that these vesicles are 
formed by weakening of bonds between the plasma membrane and the cytoskeleton, 
followed by a volume expansion driven by the intracellular pressure [166-168]. Importantly, 
PMVs formed by the FA/DTT method have been shown to have general characteristics of 
the plasma membrane, containing all major classes of phospholipids, with some 
enrichment of sphingomyelin and cholesterol. The interior of the vesicles contains 
cytosolic fluid, with no evidence of cytoskeletal structures, cytoplasmic organelles or 
nuclear fragments [163, 164]. An advantage with PMVs, apart from their representative 
membrane composition and organization, is that they lack the cellular machinery needed 
for endocytosis, making it possible to specifically study peptide-membrane interactions (as 
opposed to internalization). In this Thesis, PMVs are adapted for biophysical studies of cell 
surface binding of CPPs. The possibility to develop these vesicles for an even wider range 
of biophysical techniques makes PMVs an attractive alternative in between live cells and 
simpler membrane models.  
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4. METHODOLOGY 
This Chapter presents a short theoretical background to the main experimental techniques used for the 
work in this Thesis. 
 
4.1. SPECTROSCOPY 
The basis of all spectroscopic techniques is the interaction between electromagnetic 
radiation, i.e. light, and matter. Light consists of an electric and a magnetic field oscillating 
perpendicular to each other and to the direction of propagation. When travelling through 
space, light behaves like a wave, having a certain wavelength, frequency and polarization, but 
upon interaction with molecules, light is best described as discrete energy packages termed 
photons. Thus, light is characterized by both wave- and particle-like properties, a concept 
known as wave-particle duality. By analysing the absorption, emission or scattering of 
photons, information about a sample can be obtained at the molecular level. This section 
describes the spectroscopic techniques used in this Thesis, and the basic theory behind 
them. More comprehensive reviews on spectroscopy in general, or fluorescence 
spectroscopy, polarized spectroscopy and light scattering in particular, can be found in 
textbooks by Hollas [169], Lakowicz [131], Nordén et al. [170] and Finsy [171]. 
4.1.1. Absorption Spectroscopy 
Molecules can upon exposure to light absorb photons and thereby undergo a transition to a 
higher energy level, that is become excited. For this event to occur, the energy of the 
photon, given by its oscillation frequency (υ), must correspond exactly to the gap between 
two energetic states in the molecule (ΔE). This criterion is stated by the Bohr frequency 
condition:  

hchEEE  12    (Equation 4.1) 
where h is Planck’s constant, c is the speed of light and λ is the wavelength of the absorbed 
light. In addition, the probability of absorption is dependent on constructive interference 
between the electric field of light and the transient oscillation of the electrons as the 
molecule changes its electronic state. The oscillating field induces a dipole moment, fi , in 
the molecule given by: 
- 26 - 
 
 diffi      (Equation 4.2) 
where µ is the electric dipole operator and Ψi and Ψf the wavefuntions of the initial and 
final states respectively. fi  can be regarded as an “antenna” that must be aligned with the 
electric field vector of light for maximum probability of absorption. The absorption, A, is 
thus proportional not only to the magnitude of fi , but also to the orientation of fi  
relative to the incident light:  
 22 cosfiA      (Equation 4.3) 
where  is the angle between fi  and the electric field vector.  
The absorbance, A, can be calculated from the incident and transmitted light intensities (I0 
and I respectively) as light is passed through a sample, and depend on sample path length 
(l) and concentration of absorbing molecule (c) according to the Beer-Lambert Law: 
lc
I
I
A )(log 0      (Equation 4.4) 
where ε(λ) is the molar extinction coefficient, which is related to the oscillator strength of 
the transition in the molecule. The linear relation between absorbance and concentration 
makes absorption spectroscopy an important technique for concentration determinations, 
i.e. as a quantitative tool, and is used as such also in this Thesis. However, absorption may 
also be used to obtain more detailed information on molecular geometry or interaction. 
4.1.2. Fluorescence Spectroscopy 
Following the process of absorption, a molecule will eventually relax back to its ground 
state by dissipation of the excitation energy. This deactivation process can occur though 
both non-radiative and radiative pathways, the latter involving emission of a photon. 
Depending on the nature of the excited state, emission is in turn divided into fluorescence 
or phosphorescence. Fluorescence is emission from a singlet state, Sn, where the excited 
electron retains its spin from the ground state, making the transition spin-allowed and thus 
rapid. Phosphorescence is instead emission from a triplet state, Tn, meaning that it involves a 
quantum mechanically forbidden spin change, making it considerably slower than 
fluorescence. The excited state lifetime, , is the average time between excitation and return 
to the ground state and is typically 10 ns for fluorescence and milliseconds to seconds for 
phosphorescence. 
The photophysical processes that occur in a molecule upon absorption of light are depicted 
in the Jabłoński diagram shown in Figure 4.1. The first event following excitation from the 
ground state (S0) to a higher electronic state (Sn), is the relaxation to the lowest vibrational 
state of S1 by non-radiative vibrational relaxation (VR) and internal conversion (IC). From 
this state, there are three options for return to the ground state: (1) continued relaxation 
through non-radiative processes, (2) fluorescence emission or (3) spin conversion 
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(intersystem crossing, ISC) to a triplet state followed by non-radiative relaxation or 
phosphorescence emission. Due to the relaxation processes that precede emission, the 
energy of the emitted light is always lower in energy than the absorbed light. This red-shift 
in emission spectra is referred to as the Stoke’s shift. Also, since energy relaxation through 
emission occurs in parallel with the non-radiative processes, the efficiency of fluorescence 
emission is expressed in terms of the quantum yield )( f and depends on the rate-
constants of all deactivation pathways according to: 
ii
f
f k
k
absorbedphotons
emittedphotons
   (Equation 4.5) 
with kf being the rate constant for fluorescence emission and ii k  the sum of all rates of 
excited state decay. The intensity of fluorescence can also be reduced by a variety of 
quenching processes, e.g. collision with other molecules present in the sample or formation 
of non-fluorescent complexes. Although quenching can be used as a tool to investigate e.g. 
binding interactions or solvent accessibility, it can also be a complication when measuring 
fluorescence. In this Thesis, fluorescence is like absorption used as a quantitative tool, with 
the advantage that fluorescence can be measured in a wider concentration regime than 
absorption, and quenching is further used to investigate peptide interactions. Fluorescence 
is also utilized in techniques such as microscopy and flow cytometry to study fluorescently 
labelled peptides. 
 
Figure 4.1 A Jabłoński diagram illustrating deactivation pathways following electronic 
excitation. Solid arrows indicate radiative processes and dashed arrows indicate non-radiative 
processes. 
4.1.3. Polarized Spectroscopy 
In conventional absorption spectroscopy, both the incident light and the molecules in the 
sample are isotropic, i.e. without any preferred direction. In polarized spectroscopy, the use 
of polarized light, and in some case also oriented samples, makes it possible to obtain more 
detailed information on molecular structure, orientation and symmetry. The techniques are 
based on the differential absorption of light having different orientation. 
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Linear Dichroism 
Linear Dichroism (LD) is the differential absorption of light polarized parallel (II) and 
perpendicular (٣) to a macroscopic orientation axis:  
 AALD II      (Equation 4.6) 
In an isotropic sample, the random molecular orientations cancel out the LD signal to zero 
and in order to give rise to non-zero LD, the sample therefore needs to be anisotropic, i.e. 
macroscopically oriented. This orientation can be achieved in different ways, e.g. using 
stretched polymer films, electric fields, or, as used in this Thesis, a flow gradient. The 
principle of flow LD is schematically shown in Figure 4.2. The sample is confined to a 
narrow gap between two concentric quartz cylinders in a so-called Couette cell. Rotation of 
one of the cylinders creates a laminar shear flow that aligns the molecules in the flow 
direction. However, in order to align properly, the molecules need to be of a certain length 
and for DNA that is used in this Thesis, the lower limit is around 1000 basepairs [172]. In 
DNA, the absorption, and hence the LD signal, is dominated by the π→π* transitions of 
the bases that are oriented perpendicular to the DNA backbone and consequently also to 
the direction of orientation. Therefore, flow-oriented DNA shows a negative LD peak 
around 260 nm. 
 
Figure 4.2 The principles of flow LD using a Couette cell. The molecules in the sample are 
aligned in the shear flow that is created when one of the cylinders is rotated. 
Linear Dichroism is a useful tool to determine molecular orientation, which can be done by 
normalizing the LD signal with respect to the isotropic absorption of the sample (Aiso). This 
quotient is referred to as the reduced LD, or LDr, and is related to the angle α between the 
transition dipole moment and the macroscopic orientation axis according to: 
)1cos3(
2
3 2  S
A
LDLD
iso
r   (Equation 4.7) 
where S is the orientation factor that indicate the degree of orientation in the sample and 
equals 1 for a perfectly oriented sample and 0 for an isotropic sample. Given that the 
direction of the transition dipole moment in the molecule is known, LD can be used to 
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deduce the orientation of the molecule relative to the macroscopic orientation axis, e.g. the 
orientation of a DNA-binding ligand relative to the DNA helical axis or the orientation of 
peptides and proteins in a lipid membrane. LD can also be used to monitor changes in 
macromolecular structure that leads to a decrease in orientation, e.g. condensation of DNA 
which is studied in this Thesis. 
Circular Dichroism 
Circular Dichroism (CD) is the differential absorption between left (l) and right (r) circularly 
polarized light: 
rl AACD       (Equation 4.8) 
In order to exhibit CD, the molecules must either be intrinsically chiral or be perturbed in a 
chiral environment. A CD signal arises when light induces a helical perturbation of charge 
density. Analogous to the linear charge redistribution (µfi) induced by the electric field 
component of light, a circular rearrangement of electrons can be induced by the magnetic 
field component and this is described by the magnetic dipole moment, mfi. The origin of a 
CD signal in chiral molecules depends on µfi and mfi being non-orthogonal, thereby 
resulting in a net charge rearrangement in the form of a helix. CD is an important tool to 
study secondary structures of chiral molecules such as DNA and proteins. 
4.1.4. Dynamic Light Scattering 
Dynamic Light Scattering (DLS) is a technique that is primarily used to measure the size of 
particles typically in the submicron region. In a DLS measurement, a dilute sample is 
illuminated by a laser with a wavelength that is not absorbed by the particles in the sample. 
Most of the laser beam passes through, but a small fraction of the light is scattered in 
different directions. A detector measures the scattered light at a fixed angle and the angular 
dependence of the intensity I(q) is usually expressed in terms of the scattering vector q : 
2
sin4 
nq       (Equation 4.9) 
where n is the refractive index of the sample, λ is the wavelength of the incident light and 
 the scattering angle. The scattered light intensity will fluctuate as the particle moves at a 
rate that is proportional to the random Brownian motion, and hence to the size of the 
particles in the sample. The fluctuating intensity is used to construct a second order 
autocorrelation function (g(2)(τ)), comparing the average intensities ( I ) at time points t and 
τ = t+δt: 
2
)2(
)(
)()(
)( 

tI
ItI
g
     (Equation 4.10) 
At short time delays I(τ) ൎ I(t), since the positions of the particles are virtually unchanged 
and hence, the correlation is high )1)0(( )2( g . As the time delay increases, the particles 
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will move further away from their original positions until there is no correlation between 
the scattered intensity of the initial and final states. As this happens, the correlation curve 
will decay exponentially (Figure 4.3). For spherical particles, this decay is described by:  
  DqBeAg 22)2( 1)(     (Equation 4.11) 
where A and B are correction factors depending on the experimental setup, q is the 
previously mentioned scattering vector and D the translational diffusion coefficient of the 
particles in the sample. The latter can be determined from the autocorrelation function by 
fitting either a single-, or in the case of polydisperse samples, a multiexponential to the 
correlation function (Eq. 4.11). If the particles are assumed to be spherical, the translational 
diffusion coefficient (D), is related to the hydrodynamic radius (RH), according to the 
Stokes-Einstein equation: 
D
Tk
R BH 6      (Equation 4.12) 
where kB is Boltzmann’s constant, T the absolute temperature and η the viscosity of the 
solvent. In this Thesis DLS is used to estimate the size of complexes formed between 
CPPs and either DNA or heparin. 
 
Figure 4.3 Principles of DLS. Left: The intensity variation of the scattered light. Right: The 
decay of the autocorrelation function. 
4.2. MICROSCOPY 
Microscopy comprises a wide range of techniques, all used to visualize objects that are too 
small to be detected by the naked eye. Optical microscopy is, like spectroscopy, based on 
the interaction between light and matter and a magnified image is obtained by passing light 
that is transmitted or reflected by the sample through an objective lens. The image 
resolution (d) determines the smallest distance by which two objects are perceived as 
separate units and in general, the radiation used to visualize a sample cannot resolve details 
that are considerably smaller than its own wavelength. The second factor determining the 
image resolution is the numerical aperture of the objective, NA, which characterizes the 
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ability of the objective to collect light. This limitation in image resolution is defined in the 
Rayleigh criterion: 
NA
d 61.0      (Equation 4.13) 
NA is in turn determined by the refractive index (n) of the immersion medium between the 
objective and the specimen (usually water, n = 1.33 or oil, n = 1.52) and the half-angle of 
the maximum cone of light that can enter the objective ,  according to:  
sinnNA       (Equation 4.14) 
The resolution of an optical microscope is typically 0.2-0.5 µm, although under optimal 
conditions, using ultraviolet (UV) light sources and objectives with high numerical 
apertures (NA = 1.4), the resolution limit is about 150 nm. Eukaryotic cells that are studied 
in this Thesis are typically 10 µm in diameter and can thus be visualized with good 
intracellular detail. 
The foundation of optical microscopy described above was established more than a century 
ago [173]. However, the introduction of more modern techniques such as laser light 
sources, electronic image detection and advanced image analysis, have opened up for new 
applications. In addition, development on the sample preparation side today makes it 
possible to image live cells, stained with highly specific fluorescent markers.  
4.2.1. Fluorescence Microscopy 
Fluorescence microscopy is a widely used method in biological sciences, due to the 
possibility to specifically stain and visualize cellular structures that are invisible in normal 
light microscopy. In principle, the sample is illuminated by a specific wavelength that 
matches the excitation spectrum of the fluorescent dye. This can be done either using a 
lamp with an appropriate wavelength filter, or using a laser source that can provide a more 
coherent beam with several orders of magnitude higher intensity. The radiation excites the 
fluorophore and detects the red-shifted emitted light through a filter that excludes the 
excitation wavelength. By using multiple excitation wavelengths and/or emission filters, 
several fluorophores can also be detected simultaneously, allowing for example co-
localization to be studied. 
4.2.2. Confocal Laser Scanning Microscopy 
In conventional fluorescence microscopy, the whole sample is illuminated at all times. This 
generates fluorescence also from optical sections that are out of focus, limiting spatial 
resolution. To avoid this problem, confocal optics can be used. The basic principle is rather 
simple and involves focusing the light at any instance on a single point at a specific depth 
of the sample. This is often accomplished by the use of two pinholes; one to achieve 
focused point illumination and another to exclude out-of-focus emission from reaching the 
detector. The configuration of the two pinholes are said to be confocal, i.e. placed at 
positions so that the emission from the in-focus point come to a focus just at the detector 
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pinhole. In Confocal Laser Scanning Microscopy (CLSM), the laser scans the sample across 
the plane of focus and builds up a 2D image, and by scanning several planes consecutively, 
detailed 3D images can also be reconstructed. This technique is well suited for thick, 
scattering samples such as biological tissues and elimination of out-of focus light also leads 
to less sample damage in terms of fluorophore photobleaching, heat-induced damage and 
phototoxicity to live cells. However, the pinholes also result in one major drawback, and 
that is the limited light that reaches the detector. This means that several scans are often 
required to obtain enough information which in turn reduces the speed of acquisition. This 
is a limitation in studies of fast dynamic events, but technical advances such as spinning 
disks can reduce the acquisition time down to milliseconds. A comprehensive review of 
confocal microscopy in biological sciences is found in the textbook by Pawley [173]. In this 
Thesis, CLSM is used to study plasma membrane binding, cellular uptake and intracellular 
localization of fluorescently labelled CPPs. 
4.3. FLOW CYTOMETRY 
Flow cytometry combines the principles of light scattering and fluorescence to obtain 
multiparameter information from a sample of microscopic particles such as cells. By 
combining a high throughput with individual analysis of each cell, statistical data can be 
obtained for large cell populations.  
The basic principles and applications of flow cytometry are thoroughly described in several 
textbooks [174-176]. In short, a beam of laser light is directed onto a stream of cells 
suspended in aqueous solution. For accurate data collection, it is important that only one 
cell at a time passes through the laser light. In most flow cytometers, this is accomplished 
by hydrodynamic focusing, i.e. the cell suspension is injected into a flow stream of sheath fluid 
and the sample flow thereby becomes compressed to approximately one cell in diameter. 
An alternative approach is to use a microcapillary system, with a capacity to focus single 
cells without the use of sheath fluid [177].  
As a cell passes through the laser beam, it will scatter light in all directions and the 
instrument detects both forward scatter, which is proportional to the size of the cell, and 
side scatter at 90° angle, which is proportional to the granularity and structural complexity 
inside the cell. Usually, 2D scatter plots (Figure 4.4) is constructed from the forward and 
side scatter and cell samples can thus be characterized and divided into different 
subpopulations based on these two parameters. Additional information can be achieved by 
the use of fluorescent labelling and by using multiple excitation lasers and/or emission 
filters, several fluorophores can be detected simultaneously. By constructing scatter plots, 
single or double labelling of different fluorescent markers can be analysed and combined 
with the light scattering data, this allows for detailed analysis of complex biological systems. 
In this Thesis, flow cytometry is used to quantify plasma membrane binding and uptake of 
fluorescently labelled peptides as well as peptide-mediated transfection using Enhanced Green 
Fluorescent Protein (eGFP) as reporter protein. eGFP is a variant of the native GFP protein 
[178] that contains chromophore mutations to enhance brightness, and is codon-optimized 
for higher expression in mammalian cells [179]. 
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Figure 4.4 Analysis of flow cytometry data using scatter plots. The cell population is 
characterized based on light scattering (left) and emission (right). 
4.4. GEL ELECTROPHORESIS 
Gel electrophoresis is a common method in molecular biology used for separation of 
biological macromolecules such as DNA and proteins, for both analytical and preparatory 
purposes [135, 175, 176]. The technique is based on the electrophoretic motion of charged 
molecules in an electric field. By applying an external electric field on a sample, charged 
species will move towards the oppositely charged electrode, i.e. cationic molecules towards 
the cathode and anionic towards the anode. This motion can be described by the 
electrophoretic mobility, µ, which is determined by the ratio between the speed of the 
molecule, v, and the electric field strength, E, as well as by the ratio between the charge of 
the molecule, q, and the friction coefficient in the medium, f : 
f
q
E
v      (Equation 4.15) 
The friction coefficient f is in turn influenced by both size and shape of the molecule and 
these factors together with charge thus determine the mobility. In principle, separation can 
be achieved based on either of these factors, but separation by size is most common. 
However, for a polymer with uniform charge distribution, such as DNA, the electrical and 
frictional forces acting on each monomer unit would cancel each other out when moving 
free in solution, rendering the mobility independent of molecular size. To achieve 
separation by molecular size, the sample is therefore placed in a polymer gel and depending 
on the type and concentration of polymer, different pore sizes can be obtained. The two 
most common polymers used are agarose, which is a linear polysaccharide, and 
polyacrylamide, which is obtained by polymerizing and crosslinking acrylamide monomers. 
Due to the restricted movement in the polymer matrix, a size-, but also shape-dependent 
separation will take place, resulting in distinct bands that can be visualized by staining with 
a fluorescent dye. By comparing the pattern of bands to known standards, the contents of 
the sample can be determined empirically. In order to avoid influence from shape, the 
sample can be denaturated prior to gel electrophoresis, but the shape dependence can also 
be exploited to distinguish between different configurations, such as linear, circular and 
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supercoiled plasmid DNA. For proteins, which are more diverse than DNA in terms of 
charge and shape, separation according to size is always performed under denaturating 
conditions by treatment with the anionic detergent sodium dodecyl sulfate (SDS) in 
combination with a reducing agent to break disulfide bridges. In addition to denaturation, 
SDS also creates a uniform charge distribution and thus enables separation by size.  
Gel electrophoresis is a common technique to study both DNA and proteins, but can 
actually be used also to probe the interaction between them. Gel retardation is a widely 
used method to investigate protein-nucleic acid interactions [180] and can be used also in 
the study of DNA condensation. However, the concentrations employed in gel 
electrophoresis often result in intermolecular aggregates larger than the ~100 nm pore size 
of the gel [181], resulting in difficulties to even enter the gel. Exclusion from the gel can 
thus be a measure of DNA condensing capacity. More advanced applications include 
stability assays, such as the one used in this Thesis, where the amount of intact DNA is 
assessed following exposure to nucleases and dissociation of DNA before loading onto a 
gel. 
4.5. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
High Performance Liquid Chromatography (HPLC) is a widely used technique for 
separation of individual components in liquids and can be employed either for sample 
purification or as an analytical tool to study e.g. binding affinity [175, 176, 182]. 
The basis of all types of chromatography is the differential partitioning of compounds 
between a stationary solid phase and a liquid mobile phase. The stationary phase is most 
commonly attached to a suitable matrix (an inert, insoluble support) and packed into a 
column and the mobile phase, commonly referred to as the eluent, is passed through the 
column. In HPLC, a small particle size in the stationary phase is used, which enhances the 
chromatogram resolution by increasing the surface area, but also results in dense packaging. 
Hence, a pump (rather than gravity) is used to provide the high pressure needed to move 
the mobile phase through the column. A detector, such as a UV/Vis spectrometer, records 
the retention time(s) of the compound(s) in the eluent. The analyte retention time is 
dependent on the strength of interaction with the stationary phase, the composition of 
solvents and the flow rate through the column. Separation can either be performed with a 
constant composition of the eluent, called isocratic elution, or by gradually changing the 
eluent composition in a so-called gradient elution. In this Thesis, the technique is used to 
assess binding affinity of CPPs towards heparin, by performing a gradient elution that 
gradually weakens the intramolecular forces. 
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5. RESULTS 
In this Chapter, the most important results from Papers I-V are summarized and discussed. Some relevant 
unpublished results are also presented. 
 
The work presented in this Thesis focuses on the well-known CPP penetratin and two 
analogs named PenArg and PenLys that have previously been designed in our lab to study 
the relative importance of arginine and lysine for CPP properties and function [38, 43, 47, 
68]. This triplet of peptides were assessed in terms of their uptake efficiency and  uptake 
mechanism (Paper I), their relative affinity for the cell surface (Paper II), their dependence 
on cell surface proteoglycans for membrane association and uptake (Paper III), and finally 
their capacity to form peptiplexes and deliver  plasmid DNA into cells (Papers IV-V). 
5.1. UPTAKE OF PENETRATIN PEPTIDES 
The ability to internalize into cells is naturally a key property for a cell-penetrating peptide. 
Uptake from the extracellular environment into the cell can be considered as a two-step 
process involving (1) binding to the cell surface and (2) transport to the cell interior. 
Hence, the capacity of a CPP to internalize into cells should intuitively be governed by its 
cell surface affinity, either on its own or in combination with the ability to stimulate uptake 
at the cell surface. These questions were addressed in the work of this Thesis. 
In Paper I, the capacity of penetratin peptides to internalize into cells by triggering the cell’s 
endocytic activity was explored. The incentives behind this work came from two previous 
studies by Thorén et al. [38] and Persson et al. [47]. In the first of these studies, Thorén et al. 
studied cellular uptake by confocal microscopy and accentuated arginine-dependent 
differences in the capacity to internalize into cells was indicated, with penetratin being 
internalized via endocytosis, PenArg via both endocytosis and direct penetration, while 
PenLys was seemingly unable to enter cells at all. This prompted us in Paper I to explore 
uptake in a quantitative manner and also to look further into the uptake mechanism. In the 
second study mentioned above, Persson et al. tried to explain the diverging uptake 
capacities of PenArg, penetratin and PenLys in terms of differences in membrane affinity, 
but found only a 3-fold difference in surface partition constants for anionic lipid 
membranes. This pointed towards that membrane affinity was not decisive for uptake, and 
we therefore decided to instead search for differences in the capacity to trigger an uptake 
response. Therefore, in Paper I, the ability of the penetratin peptides to stimulate 
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macropinocytosis was assessed, as it had recently been found to be involved in uptake of 
arginine-rich peptides such as Tat [144, 183] and oligoarginines [82, 91].  
Cellular uptake of fluoresein-labelled penetratin peptides was studied using both a 
quantitative uptake protocol to directly compare their uptake efficiencies, and confocal 
microscopy to assess their intracellular localization. Figure 5.1A shows the relative uptake 
of penetratin peptides in Chinese hamster ovarian cells (CHO-K1) after 1 h incubation. To 
ensure complete removal of extracellularly bound peptide, the cells were washed with 
heparin (100 µg/ml, which is 10 times the concentration needed to completely inhibit cell 
surface binding of the CPP Tat [144]), prior to trypsination and subsequent cell lysis. In the 
investigated concentration regime (1-10 µM), the uptake levels are nearly linearly dependent 
on concentration and are clearly in the order PenArg > penetratin > PenLys. PenArg is 
roughly 10 times more efficiently internalized than PenLys. These results show that 
arginines are beneficial, but not a prerequisite, for uptake and that substituting arginines for 
lysines leads to a gradual decrease in uptake, but not complete inhibition, which had been 
previously suggested [38]. 
 
Figure 5.1 Uptake of penetratin peptides in CHO-K1. (A) Peptide uptake after 1 h incubation 
at 37˚C as a function of peptide concentration. The bars represent the average of nine independent 
experiments, performed in triplicate (N=9, n=3). Error bars indicate the average maximum and 
minimum deviation in each experiment. (B) Confocal images of live CHO-K1 cells showing 
uptake of FITC-labelled peptide (5 M, green) and its co-localization with the non-specific 
endocytosis marker FM4-64 (5 g/ml, red) after 1 h incubation at 37˚C. The image contrast and 
detector gain was optimized for each micrograph and the intensities in each image are thus not 
comparable. (C) Uptake and distribution of PenArg applied at 10 M concentration showing 
compromised cell morphology. 
Peptide internalization was also studied using confocal microscopy and co-incubation with 
FM4-64, which is a general marker for endocytosis. FM4-64 is a lipophilic styryl dye that is 
virtually non-fluorescent in aqueous media but becomes intensely fluorescent once inserted 
into the membrane. It is unable to translocate the membrane directly but is internalized 
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into endocytic vesicles. Figure 5.1B shows confocal images of CHO-K1 cells incubated 
with 5 µM of penetratin peptides and FM4-64 for 1 h. The punctuate intracellular 
distribution and substantial co-localization with FM4-64 verifies mainly endocytic uptake 
for all three peptides. No diffuse cytosolic staining (which would suggest direct penetration 
or highly efficient endosomal escape) was observed except occasionally for PenArg at the 
highest peptide concentration (10 µM, Figure 5.1C). However, diffuse cytoplasmic staining 
was in this case accompanied by severely compromised cell morphology, which either 
means that direct penetration leads to toxicity or the opposite; that membrane-mediated 
toxicity results in peptide penetration. 
5.1.1. Stimulation of Endocytosis 
The ability of the penetratin peptides to stimulate macropinocytosis was assessed by 
co-incubating peptide with markers of endocytosis. A high molecular weight (70 kDa) 
neutral dextran labelled with Texas Red (TR-dextran) was used to specifically probe 
macropinocytosis [184]. As reference, the overall endocytic activity was determined by the 
uptake of FM4-64. We wanted to explore macropinocytic stimulation in a quantitative 
manner and Figure 5.2A-B shows the extent of TR-dextran and FM4-64 uptake 
respectively, both in the absence (control) and presence of penetratin peptides. Addition of 
peptide markedly increases internalization of TR-dextran to a degree that is dependent on 
both peptide concentration and arginine content, and thus in qualitative agreement with 
peptide internalization. By contrast, uptake of FM4-64, end hence the overall endocytic 
activity, is essentially unaffected by peptide addition except at 10 µM of PenArg. We 
believe that due to the toxicity observed for PenArg at this concentration, internalization of 
FM4-64 is most likely exaggerated as a consequence of increased membrane permeation. 
Uptake of TR-dextran was also studied by confocal microscopy and from Figure 5.2C, it is 
evident that addition of peptide increases the uptake of TR-dextran. Co-localization 
between peptide and TR-dextran is however not perfect, which means that the penetratin 
peptides are not exclusively internalized via one endocytic pathway. This is also in 
agreement with previous observations that several mechanisms are involved in penetratin 
uptake [55]. 
The main conclusion from Paper I was that the penetratin peptides can trigger their own 
uptake by specifically stimulating macropinocytosis. Since the overall endocytic activity 
remains largely constant, this macropinocytic up-regulation occurs at the expense of other 
endocytic pathways. Moreover, arginine- and lysine-rich penetratin versions have at least 
some internalization mechanism in common, although lysines are less efficient. This 
demonstrates that events leading to stimulation of endocytosis are not dependent on 
specific interactions with arginine sidechains. Still, arginines clearly evoke a higher response 
than lysines, which means that arginines either have higher affinity for uptake-triggering 
membrane sites, or that arginines can form specific interactions with additional binding 
sites and trigger uptake via pathways that are not accessible to lysines. These questions were 
addressed in Papers II-III, where the importance of cell surface affinity versus uptake 
stimulation for internalization of arginine- and lysine-rich penetratin versions was explored 
(sections 5.2.-5.4.).  
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Figure 5.2 Peptide-induced stimulation of macropinocytosis in CHO-K1. (A) Internalization 
of the non-specific endocytosis marker FM4-64 (5 g/ml) in absence (control) and presence of 
penetratin peptides (PenLys, penetratin and PenArg). (B) Internalization of macropinocytic 
marker TR-dextran (100 g/ml) in absence (control) and presence of penetratin peptides. (C) 
Uptake of TR-dextran (50 g/ml) in absence and presence of peptide (5 M PenLys). In all 
experiments, the cells were incubated for 1 at 37°C. The bars in (A) and (B) represents the average 
of three independent experiments, performed in triplicate (N=3, n=3). Error bars represent the 
average maximum and minimum deviation in each experiment. 
To obtain further insight into the mechanism by which penetratin peptides trigger 
macropinocytic up-regulation, we decided to explore known stimulators of 
macropinocytosis. Transient induction of cell surface ruffling and macropinocytosis can for 
example be obtained by growth factor stimulation and one of the most well-known 
stimulators of macropinocytosis is the epidermal growth factor (EGF) [185]. EGF is a 53 a.a. 
peptide that induces membrane ruffling by binding to the EGF receptor, which then 
triggers activation of receptor tyrosine kinases that in turn leads to intracellular signalling 
cascades [151]. We decided to explore macropinocytic stimulation of penetratin peptides 
using EGF as a reference, and unpublished data from these studies are presented below 
(Figure 5.3 and 5.4).  
First, since EGF is known to stimulate macropinocytosis already at nanomolar 
concentration [185], the capacity of the penetratin peptides to evoke a response in this low, 
but biologically relevant, concentration regime was investigated. Figure 5.3 shows confocal 
images of CHO-K1 cells incubated with TR-dextran and 2 nM of EGF, PenArg, penetratin 
or PenLys for 1 h. This shows that PenArg and penetratin have a stimulatory capacity that 
is comparable to EGF, while PenLys is less efficient. The fact that these peptides are such 
competent stimulators of macropinocytosis is intriguing. However, since EGF binding to 
the EGF receptor is known to involve specific interactions with three large domains in the 
EGF sequence [186], it is unlikely that the penetratin peptides can stimulate 
macropinocytosis through this receptor. Instead, it seems as if signalling cascades that 
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activate macropinocytosis can be initiated by binding of penetratin to additional cell surface 
binding sites. The nature of these sites and the mechanism by which penetratin can trigger 
macropinocytosis remains to be identified, but one hypothesis suggested in the literature is 
that clustering of proteoglycan chains by cationic peptides could trigger endocytosis [76, 
77]. 
 
Figure 5.3 Stimulation of macropinocytosis at nanomolar peptide concentrations. 
Internalization of macropinocytic marker TR-dextran (50 g/ml) in presence of 2 nM epidermal 
growth factor (EGF) or penetratin peptides (PenArg, penetratin, PenLys) after incubation for 1 h 
at 37°C. 
Another question that was raised during the work presented in Paper I was whether the 
penetratin peptides would only stimulate their own uptake at the site where they were 
bound, or if signalling cascades could be initiated that would enhance macropinocytic 
activity across the entire cell, thereby also increasing uptake of other molecules. In the latter 
case, it should be possible to improve uptake of a poorly internalized CPP by addition of 
another peptide with a strong capacity to stimulate macropinocytosis. To address this 
question, the ability of unlabelled peptide, applied at nanomolar concentration, to enhance 
uptake of another fluorescein-labelled peptide applied in micromolar concentration, was 
investigated. Figure 5.4 shows uptake of 5 µM fluorescein-labelled PenLys (F-PenLys) in 
absence (control) or presence of three different concentrations of either PenLys itself, 
PenArg or EGF (as reference). With 5 nM unlabelled peptide added simultaneously to 
5 µM F-PenLys, EGF enhances F-PenLys uptake by approximately 20%, which is similar 
to what has previously been observed for octaarginine [91], and gives further support to 
the involvement of macropinocytosis in PenLys uptake. In contrast, PenLys and PenArg 
only have a marginal effect with less than 10% difference from F-PenLys alone and PenArg 
even show a tendency to inhibit F-PenLys uptake. These results show that whereas EGF 
has some capacity to enhance F-PenLys uptake by increasing the overall macropinocytic 
activity, the penetratin peptides appear to stimulate uptake specifically at the site where they 
bind.  
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To investigate whether a larger stimulatory effect could be achieved, the concentration of 
unlabelled peptide was increased to 50 and 500 nM, and in addition the cells were 
pre-incubated with peptide for 1 h before addition of 5 µM F-PenLys, in order to trigger 
macropinocytic activity in advance. However, instead of obtaining a stimulatory effect, 
uptake of F-PenLys was inhibited under these conditions. Interestingly, pre-incubation 
with EGF was strongly inhibiting and it is possible that EGF at these elevated 
concentrations exhausts the cell’s endocytic machinery during the pre-incubation step and 
thereby prohibit subsequent F-PenLys uptake. It may also be that EGF binds, and thereby 
blocks, PenLys binding sites when specific receptor binding becomes saturated. Pre-
incubation with PenLys and PenArg results in concentration- and arginine- dependent 
inhibition of F-PenLys uptake. This might be caused by saturation of peptide uptake upon 
prolonged incubation, which is supported by observations that uptake of penetratin 
peptides level off after 1 h incubation (see Figure 1 of Paper III). An alternative explanation 
is that unlabelled peptide during the co-incubation competes for uptake-promoting cell 
surface binding sites and that PenArg thereby outcompetes F-PenLys. This would in turn 
mean that peptide affinity for the cell surface is decisive for uptake, a topic which was also 
addressed in Paper II. 
 
Figure 5.4 PenLys uptake cannot be enhanced by macropinocytic stimulation by other 
peptides. Uptake of 5 µM fluorescein FITC-labelled PenLys after 1 h incubation at 37°C in 
absence (control) or presence of 5, 50 or 500 nM unlabelled PenLys, PenArg or epidermal growth 
factor (EGF). The data represent mean ± S.D. from 3 samples. *Unlabelled peptide was added 1 h 
prior to addition of FITC-PenLys. 
The conclusion from these experiments was that penetratin peptides efficiently stimulate 
macropinocytosis and, like EGF, evoke this biological response already at nanomolar 
concentrations. The stimulation appears however local and occurs specifically at the site 
where the peptide binds. On the one hand, this means that these peptides are capable of 
stimulating their own internalization, but cannot be used to enhance uptake of other 
therapeutic molecules. On the other hand, this may also be advantageous as unspecific 
internalization of unwanted molecules upon treatment with CPPs could increase the risk of 
side-effects.  
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5.2. CELL SURFACE BINDING OF PENETRATIN PEPTIDES 
Binding to the cell surface is the first step towards internalization of CPPs and it is also the 
focus of Paper II in this Thesis. Although it seem intuitive that the membrane binding 
affinity of a particular CPP should be important for its corresponding uptake efficiency, 
some reports in the literature suggest that no such correlation exists [88, 187] and previous 
work from our group has revealed only weak connections between uptake and peptide-lipid 
interactions [43, 47]. This suggests that uptake could be primarily dependent on the 
peptide’s capacity to evoke a biological response that triggers internalization, as was 
observed in Paper I, and to a lesser extent on the amount of peptide that resides on the cell 
surface. However, the lack of correlation between model membrane binding and uptake 
could also depend on that the lipid vesicles are too simplified to accurately describe 
peptide-cell surface interactions. In Paper II, we therefore explored the influence of arginine 
and lysine on cell surface binding of penetratin in a more complex model. This was 
assessed using plasma membrane vesicles (PMVs) released directly from CHO-K1 cells in 
response to treatment with formaldehyde (FA) and dithiothreitol (DTT) (Figure 5.5). 
PMVs, which are more thoroughly described in section 3.3.3., have previously been used 
for a number of applications [158-162], but is a novel model system for studies of CPP-
membrane interactions. Binding of fluorescein-labelled peptides to PMVs was studied 
using both confocal microscopy and a developed protocol based on spectroscopic 
quantification of free and vesicle-associated peptide fractions, separated by centrifugation. 
 
Figure 5.5 Production of plasma membrane vesicles (PMVs) from live cells.          
(A), (B) CHO-K1 cells treated with vesiculation chemicals producing PMVs. (C) Purified PMVs 
harvested after 15 hours of vesiculation. Scale bar = 10 μm. 
Figure 5.6 shows binding of the three penetratin peptides to PMVs imaged by confocal 
microscopy. While PenArg and penetratin show clear accumulation in the PMV 
membranes, PenLys displays much weaker membrane association, suggesting that the 
peptides indeed have different affinities for the PMV membranes. In addition, while the 
aim of this study was to purely monitor membrane binding (and not internalization), 
vesicles with more diffuse fluorescence was also observed and at longer incubations 
(> 30 min), membrane fragments started to appear (see Figure 2 of Paper II). Nevertheless, 
from control experiments, it was found that these vesicles were not intrinsically leaky, since 
low molecular weight soluble carboxyfluorescein (CF) was essentially excluded from the 
PMV lumen (Figure 5.7A). Furthermore, staining with an RNA-specific probe 
demonstrated that these vesicles contain RNA (Figure 5.7B). These findings altogether 
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point to that the penetratin peptides indeed have some inherent capacity to enter and also 
disrupt these vesicles with time, and that peptide accumulation inside PMVs could be 
driven by its high affinity for negatively charged RNA. It is however questionable whether 
the internalization observed in PMVs is occurring to high extent in live cells, where uptake 
is mainly endocytic (Figure 5.1). 
 
Figure 5.6 Penetratin peptides display different patterns of binding to PMVs. (A) PenLys, 
(B) penetratin, (C) PenArg. PenArg and penetratin show clear membrane association, while 
PenLys gives more diffuse fluorescence with no clear membrane localization. Images acquired 
15 minutes after addition of peptide. Contrast and gain have been optimized for each image and 
the intensities are thus not directly comparable. Scale bar = 5 μm. 
While the confocal images indicated differences in membrane affinity among the penetratin 
peptides, we also wanted to obtain quantitative data. This was done by briefly incubating 
PMVs with peptides (1-10 µM), followed by centrifugation to sediment the bound fraction, 
and spectroscopic quantification of the fluorescein label. As some peptide translocation 
was observed under the confocal microscope, control experiments were also performed to 
make sure that membrane binding rather than intravesicular binding (i.e. to RNA) was 
quantified. To this end, PMVs were subjected to freeze-thawing (liquid N2/37°C) prior to 
peptide incubation, which will open up and reseal vesicles and hence release intravesicular 
content. Figure 5.8 shows the amount of peptide found in the pellet fraction as a function 
of total amount of peptide added to the sample, for both untreated and freeze-thawed 
PMVs. First of all, these are within experimental error identical, suggesting that peptide 
internalization does not contribute significantly to the fraction found in the pellet. 
Secondly, and most importantly, the penetratin peptides have strikingly different affinities 
for the PMVs. At both 5 and 10 µM added peptide, approximately 90% of PenArg is 
bound to PMVs, whereas the corresponding amount for penetratin and PenLys are ~60% 
and ~15% respectively, clearly showing that arginines strongly promote binding. Binding 
constants cannot be directly calculated from these data, since we do not know the exact 
nature or quantity of binding sites present, but using a simple binding equilibrium the ratio 
between the binding constants for PenArg and PenLys can be estimated to KPenArg/KPenLys 
  34 (see Supplementary information of Paper II for derivation). 
- 43 - 
 
 
Figure 5.7 PMV membrane integrity and contents. (A) Staining with membrane marker 
FM4-64 (20 μg/ml) and external addition of carboxyfluorescein (CF, 5 μM). Image acquired 
10 min and after addition of dyes. (B) Staining with FM4-64 (20 μg/ml) and RNA-specific 
SYTO RNASelect (3 μM) acquired after 5 min incubation. Intensity profiles along the lines 
indicated in the confocal images are shown in panels to the right. Scale bar = 5 μm. 
The results in Paper II show that by using plasma membrane vesicles as a model of the cell 
surface, we obtain striking differences in membrane binding between the penetratin 
peptides. Such marked differences have not been observed when using lipid vesicles, where 
surface partition constants differ roughly by a factor 3 [47]. We hypothesised that an 
explanation for these discrepancies might be that the penetratin peptides primarily 
associates with proteoglycans on the cell surface. This question was indeed addressed in 
Paper III where the influence of PGs on cell surface binding and subsequent internalization 
of the penetratin peptides was explored (section 5.3.). However, the fact that dissociation 
constants for interaction with heparin in vitro differs only by a factor 2-3 between individual 
arginine and lysine residues [188] points to that cell surface interactions of CPPs involves 
several cell surface moieties and that the complexity and molecular organization of the cell 
surface therefore is important to adequately describe peptide binding.  
Regardless of the molecular details involved in peptide binding to the cell surface, Paper II 
clearly demonstrates accentuated arginine-dependent differences in cell surface affinity. 
This means that the previous suggestions that membrane binding is not decisive for 
internalization efficiency of penetratin peptides needs to be re-evaluated and that cell 
surface binding and uptake indeed seem to correlate. The relation between cell surface 
binding and uptake efficiency was explored in detailed in both Paper II and III and this 
topic is further discussed in section 5.4. 
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Figure 5.8 Quantification of peptide binding to PMVs. PMVs were incubated with 
FITC-labelled penetratin peptides for 10 min, followed by separation of bound and free peptide 
fractions by centrifugation. Binding curves show concentration of peptide in the pellet fraction 
(calculated as ctot-csupernatant) as a function of total peptide in each sample. Dashed lines represent 
binding to PMVs that had been subjected to 5 freeze-thaw cycles (liquid N2/37°C) to remove 
intravesicular content prior to addition of peptide, while solid lines represent binding to untreated 
PMVs.  
5.3. THE ROLE OF PROTEOGLYCANS 
Proteoglycans have been suggested to be key players in the uptake of several CPPs [82-89], 
especially those rich in arginines [82-88], but also for penetratin [83, 88, 89]. In Paper III, we 
therefore wanted to specifically investigate the role of proteoglycans in membrane 
interaction and uptake of arginine- and lysine-rich penetratin versions. The dependency of 
penetratin uptake on these moieties was studied using wild-type CHO-K1 and 
proteoglycan-deficient mutant CHO-pgsA745 cells (denoted A745). The latter lacks the 
enzyme xylosyltransferase which is needed in the first step of glycosaminoglycan synthesis, 
and is hence deficient in all GAGs [189]. The ability of the penetratin peptides to bind and 
cluster sulfated sugars in vitro were also studied, using heparin as mimic for cell surface 
GAGs. 
5.3.1. Proteoglycans in Cell Surface Binding and Uptake 
The importance of cell surface proteoglycans was first assessed by comparing both cell 
surface association and uptake of penetratin in CHO-K1 and A745 cells. Uptake was 
examined in a similar manner as in Paper I, but instead of quantifying peptide in cell lysates, 
the cells were analysed by flow cytometry after treatment with heparin and trypsin, and the 
data represents the mean fluorescence from each counted cell. To quantify extracellular 
membrane binding, the protocol was adjusted so that peptide incubation was performed 
for 15 minutes on ice to block endocytic uptake, and in addition, cells were detached non-
enzymatically to avoid peptide degradation prior to analysis. Figure 5.9 shows both cell 
surface binding and uptake of penetratin in concentrations ranging from 1-15 µM. What is 
most striking is that binding to the cell surface is virtually independent of the presence of 
proteoglycans, whereas uptake of penetratin is strongly enhanced when PGs are present, 
which is in accord with previous uptake studies in PG-deficient cells [83, 88, 89]. This 
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comparison was also extended to include the influence of arginines and lysines and 
Figure 5.10 shows binding and uptake of PenLys, penetratin and PenArg at both 5 and 
10 µM concentration. Here, it is evident that arginines are beneficial for both binding and 
uptake, not only in wild-type CHO-K1 as observed in Paper I and II, but also in the absence 
of proteoglycans as shown in A745 cells. Moreover, as could be seen for penetratin in 
Figure 5.9, presence of proteoglycans does not significantly increase the membrane affinity 
of these peptides. By contrast, proteoglycans provide an enhanced capacity to internalize 
both lysine- and arginine-rich peptides.  
 
Figure 5.9 Proteoglycans increase uptake of penetratin, but not cell surface binding.      
Cell surface binding (left) and cellular uptake (right) of penetratin was measured as a function of 
peptide concentration. Cell surface binding was measured after 15 min incubation of cells at 4°C 
to exclude endocytic uptake. The cells were detached with non-enzymatic cell dissociation solution 
to avoid degradation of extracellularly bound peptide. Cellular uptake was measured after 1 h 
incubation at 37°C, followed by washing with heparin (100 µg/ml) to remove extracellular peptide. 
Experiments were performed in both CHO-K1 (filled squares) and PG-deficient A745 (open 
circles) cells. Binding and uptake was determined as the mean fluorescence of cells analysed by 
flow cytometry. The data points represent the mean (± S.D.) from 5 samples. 
We further investigated whether presence or absence of cell surface proteoglycans altered 
the internalization pathways and hence intracellular distribution of peptide. A punctuate 
uptake pattern confirmed that uptake was endocytic also in the A745 cell line. However, 
for 10 µM PenArg, toxicity was observed, as indicated by altered cell morphology, staining 
with dead cell marker 7-AAD together with extensive cytoplasmic peptide localization. 
This toxic response was more pronounced in the A745 cells and representative confocal 
images are shown in Figure 5.11. Hence, our results show that PGs, in addition to promote 
uptake, also protect against cytotoxicity, which has previously been observed also with 
cationic lipids [190] and antimicrobial peptides [191].  
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Figure 5.10 Cell uptake and binding are promoted by arginines in both CHO-K1 and A745. 
Cell membrane binding (left) and uptake (right) for 5 µM (top) or 10 µM (bottom) PenLys, 
penetratin and PenArg in CHO-K1 and PG-deficient CHO-A745 cells. Cells were incubated for 
15 min at 4°C (binding) or 1 h at 37°C (uptake). The data points represent mean fluorescence 
intensity (± S.D.) of gated live cells from 3 separate samples. Note the different scales in the four 
graphs. *Peptide-mediated toxicity occurs for 10 µM PenArg (see Figure 5.11) but dead cells were 
excluded from the analysis. 
The fact that PGs have only minor effect on the amount of membrane-associated peptide 
was rather surprising, since a lack of these heavily negatively charged moieties should 
intuitively reduce the cell surface affinity for cationic penetratin peptides. From what can 
be found in the literature, the only difference in cell surface composition between 
CHO-K1 and A745 cells is that the latter completely lack all GAG chains [189]. However, 
we speculated that the expression of other anionic cell membrane components could 
potentially be upregulated in A745 cells in order to compensate for the loss of negative PG 
charge and decided to address the question of overall cell surface charge experimentally by 
measuring the zeta potential of both CHO-K1 and A745 cells. We found a mere ~10% 
difference between the cell lines, which means that other negatively charged cell surface 
moieties such as anionic lipids or glycoproteins are indeed present at high concentrations 
and thereby compensate for the lack of PGs. Interestingly, PenArg was the only peptide 
that showed enhanced membrane binding in presence of PGs, which indicate that arginines 
indeed have higher affinity for PGs compared to other membrane components, but also 
that a high local concentration of arginines are required to promote PG binding. The latter 
would be consistent with previous observations that at least four arginines are required for 
internalization of oligoarginines [36]. However, for both penetratin and PenLys, other 
anionic moieties serve equally well as membrane binding sites. Therefore, the main 
conclusion from these experiments was that proteoglycans are primarily important for 
stimulating uptake of peptide at the cell surface and not for providing cell surface affinity.  
A possible explanation for the uptake-triggering interactions of penetratin peptides with 
proteoglycans may be that they have a positive charge distribution that favour specific 
binding to PG chains. Heparin-binding proteins often contain consensus sequences that 
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result in an oriented display of positive charge upon formation of α-helix or β-sheet 
secondary structures [192, 193]. The penetratin peptides have indeed been shown to adopt 
such amphipathic secondary structures when binding to membranes [43, 104, 105] and in 
addition, the C-terminal domain of penetratin actually contains a heparin binding motif 
(NRRMKW = xBBxBx, where B is basic and x neutral or hydrophobic), that could 
potentially be involved in forming specific interactions with GAG chains on the cell 
surface. 
 
Figure 5.11 Uptake is mainly endocytic and PenArg toxicity is dependent on 
proteoglycans. Confocal images of live CHO-K1 (left) or A745 cells (right) incubated with 5 µM 
(top) or 10 µM (bottom) of PenArg for 1 h at 37°C and stained with dead cell marker 7-AAD 
(1 µg/ml). Contrast and gain have been optimized separately for each image. For penetratin and 
PenLys, a punctuate uptake pattern with no signs of toxicity was observed in both cell lines. 
In conclusion, the results from Paper III presented above demonstrate that lysine- and 
arginine-rich penetratin versions can be internalized via both PG-dependent and PG-
independent endocytosis. However, a lack of cell surface proteoglycans markedly reduce 
uptake, while cell surface association is mostly unaffected. These findings provide 
mechanistic insight regarding the role of PGs in CPP uptake and suggest that PGs, rather 
than having a passive role, only recruiting peptide to the cell surface, are responsible for 
triggering internalization of cell surface-associated peptide. In addition to this uptake-
promoting role, PGs were also found to reduce peptide-mediated toxicity for PenArg, 
probably by preventing direct membrane interaction. Moreover, arginines were 
demonstrated to be beneficial for both binding and uptake, regardless of the presence of 
PGs. This means that arginines interact more readily also with other cell surface 
components, which likely contributes to their superior uptake efficiency. 
5.3.2. Biophysical Studies of Peptide - Heparin Interactions 
In Paper III, the effect of arginine and lysine substitution on the interaction between 
penetratin and proteoglycans was investigated also in vitro with heparin as a model for 
sulfated sugars on the cell surface. The relative heparin affinity of these peptides was 
assessed using heparin affinity chromatography and Figure 5.12 shows the elution profiles 
when either sodium chloride (NaCl) or guanidinium hydrochloride (GdnHCl) gradients 
(0-3 M) were used for elution. While NaCl is only capable of breaking ionic interactions, 
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GdnHCl is a chaotropic agent that is able to disrupt also hydrogen bonding and 
hydrophobic contributions to peptide-heparin binding. In addition, since guanidinium has 
the same chemistry as the arginine headgroup, it may be considered as a more direct 
competitor for arginine binding sites.  
 
Figure 5.12 Peptide affinity for heparin increases with arginine content. Heparin sepharose 
affinity chromatograms of CF-labelled penetratin peptides in 50 mM sodium phosphate buffer pH 
7, eluted with 0-3 M NaCl (A) or GdnHCl (B). The increasing salt gradient is shown as dashed 
lines. (C) Summary of the parameters retrieved from the chromatograms. 
Independent of type of salt, the peptides eluted from the column in the order PenLys – 
penetratin – PenArg, which confirmed that arginines have higher affinity for heparin in 
accord with previous work comparing arginine- and lysine-rich peptides [188]. The longer 
retention times for arginine-containing penetratins was also accompanied by peak 
broadening, suggesting that PenArg and penetratin bind to heparin with a distribution of 
binding modes with different affinity or that binding may be cooperative. The arginine-
dependent peak broadening was much more prominent with NaCl as eluent. Moreover, 
based on the peak area, a major fraction (~70%) of PenArg binds so strongly to heparin 
that it cannot be displaced at all by 3 M NaCl. Changing eluent to GdnHCl had little effect 
on PenLys, but resulted in shorter retention times and significantly sharper peaks for both 
PenArg and penetratin. PenArg was in this case completely eluted from the column. This 
shows that whereas PenLys interaction with heparin is strictly electrostatic, PenArg and 
penetratin binding is stabilized by additional contributions, such as hydrophobic 
interactions and hydrogen bonding. This confirms that arginines due to the guanidinium 
headgroup have a superior capacity to bind to sulfated sugars on the cell surface [130]. 
Clustering of heparan sulfate chains at the cell surface has been suggested to initiate uptake 
of CPPs [76, 77] and several studies have also reported CPP-induced clustering in vitro [78-
81]. The arginine-dependent capacity of penetratin to induce clustering of heparin chains in 
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solution was therefore investigated by dynamic light scattering and the average 
hydrodynamic diameter of the formed peptide-heparin complexes are presented in 
Figure 5.13. Data is shown for two different charge ratios (charge ratio, r, equals the 
number of positive peptide charges divided by the number of negative heparin charges, i.e. 
r = [+]/[–]). Whereas all three peptides form stable complexes with an apparent diameter 
of ~250 nm at r = 0.25, both penetratin and PenArg form larger particulates, probably 
formed by aggregation of several complexes, at r = 0.5. These results are thus consistent 
with that arginines bind heparin with a certain degree of cooperativity and furthermore 
correlate qualitatively with the corresponding uptake levels of each peptide.  
 
Figure 5.13 The capacity to cluster heparin is arginine-dependent. Dynamic light scattering 
measurements of penetratin peptides and heparin mixed at charge ratios (+/−) r = 0.25 (left) and 
r = 0.5 (right). A small volume of peptide was added to 10 µM heparin in 10 mM sodium 
phosphate/150 mM NaCl pH 7.4 and the size of the formed complexes were measured at 
different time-points. The data represents the mean size by intensity and the error bars the size 
distribution width. 
In conclusion, the biophysical studies of penetratin – heparin interactions confirms that 
arginines bind sulfated sugars with higher affinity than lysines, and furthermore that 
arginines can promote clustering of several GAG chains. Both of these observations could 
provide a possible explanation for the superior capacity of arginine-rich peptides to bind 
and internalize into cells when PGs are present. However, the fact that arginines promote 
binding and uptake also in cells lacking PGs suggest that arginines are superior to lysines in 
forming favourable interactions also with other cell surface components. These questions 
will be discussed in the following section. 
5.4. THE CORRELATION BETWEEN BINDING AND UPTAKE 
The results presented in Papers I-III altogether suggest that arginines promote penetratin 
uptake both by increasing cell surface affinity and by triggering internalization. On one 
hand, the penetratin peptides show arginine-dependent capacities to cluster heparin in vitro 
and also to induce macropinocytosis in vivo, pointing towards that PenArg and PenLys 
differ in uptake levels due to different capacities to trigger uptake at the cell surface. On the 
other hand, these peptides have markedly different affinities for the cell surface, that also 
correlates with their uptake levels. This leads to the imperative question, which of these 
two factors are most important for uptake? 
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To address this matter, uptake was investigated as a function of cell surface binding. Such a 
comparison was made for the first time in Paper II, where uptake data from Paper I was 
plotted against peptide binding to plasma membrane vesicles (Figure 6 of Paper II). 
However, in Paper III, we expanded this analysis to include also the influence of 
proteoglycans and the results obtained from this study are shown in Figure 5.14, where 
uptake of 1, 5 or 10 µM of PenArg, penetratin or PenLys is plotted as a function of their 
corresponding cell surface binding in both CHO-K1 and A745 cells. These “uptake-
binding plots” are linear (linear regressions are shown for easier comparison), showing that 
for each peptide the amount that is internalized corresponds directly to the amount that 
bound to the cell surface. Hence, there is a direct correlation between uptake and cell 
surface affinity. Moreover, these plots can be used to compare peptides or to compare 
uptake in the two cell lines. Equal slopes signify that two peptides have equal capacity to 
internalize into cells once bound to the cell surface. However, the fact that the magnitude 
of the slopes differ (see Figure 5.14) means that there are both arginine- and proteoglycan-
dependent differences in the capacity to internalize membrane-associated peptides. First, 
the slopes are generally steeper in CHO-K1 than in A745, which means that uptake into 
wild-type cells is more efficient than into PG-deficient A745, even when taking into 
account peptide affinity for their surfaces. Furthermore, whereas the slopes are relatively 
similar in CHO-K1 (which is in agreement with what was found also in Paper II using 
PMVs), there are more accentuated differences between the peptides in A745 cells. 
Importantly, this signifies a stronger dependence on arginines for internalization of CPPs 
via non-PG binding sites. 
 
Figure 5.14 Cell uptake and binding of penetratin peptides show a linear correlation. 
Plotting uptake as a function of membrane binding for 1, 5 and 10 µM PenArg, penetratin or 
PenLys indicate the ability of each peptide to internalize into CHO-K1 (left) and A745 (right) cells 
once bound to the membrane. The lines represent linear regression of data and the slopes (k) are 
indicated in the graph legends.  
In conclusion, PG-dependent uptake is primarily dependent on peptide membrane affinity, 
which is in accord with classical descriptions of adsorptive endocytosis [194]. Also, despite 
that binding cooperativity and clustering of heparin was observed for arginines in vitro, the 
linear appearance and lack of upward curvature in Figure 5.14 excludes that cooperative 
peptide binding events are required to trigger uptake. This further implies that the 
differential capacity of these peptides to trigger macropinocytosis observed in Paper I 
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primarily depends on the amount of peptide that binds to uptake-triggering sites, instead of 
specific interactions with arginine side chains. By contrast, uptake via non-PG sites depends 
on a combination of peptide membrane binding and the subsequent triggering of endocytic 
uptake, with arginines being superior for both of these events. This is important, since it 
means that arginines are more versatile than lysines in terms of using several portals of 
entry into the cell. Altogether, these results also emphasize the necessity of determining 
both membrane binding and uptake before drawing conclusions regarding the molecular 
mechanisms underlying uptake, since what might be interpreted as a specific uptake-
triggering response could instead be a strong membrane binding affinity. 
5.5. PENETRATIN PEPTIDES AS DNA VECTORS 
While the results presented so far have focused on fundamental cell surface interactions 
and mechanisms behind CPP internalization, Paper IV instead concerns the capacity of 
these peptides to function as DNA delivery vectors. Non-covalent approaches for utilizing 
CPPs as vectors for nucleic acids are becoming increasingly popular [195], but the basic 
interactions between the two remains largely unexplored. In Paper IV, a range of 
biophysical techniques in combination with transfection experiments were used to 
investigate DNA condensation, the stability of the formed peptide-DNA-complexes 
(“peptiplexes”), and their corresponding capacity to mediate gene delivery. A systematic 
comparison of the seven commonly used CPPs penetratin, PenArg, PenLys, Tat, 
octaarginine (R8), transportan and MPG was performed. These peptides differ in net 
charge, arginine/lysine content and hydrophobicity (see Table 2.1 for sequences), and were 
chosen to address the influence of these peptide properties for non-covalent gene delivery. 
Since penetratin and the relative importance of arginines and lysines is the focus of this 
Thesis, the results for penetratin, PenArg and PenLys will be presented below, although 
results with the other peptides will also be referred to in order to discuss more general 
conclusions about the role of hydrophobic contributions and arginine content for non-
covalent gene delivery. 
5.5.1. Condensation of DNA 
Efficient packaging of DNA into peptiplexes is important to facilitate uptake, but also to 
protect DNA from degradation by extra- and intracellular nucleases. Condensation of 
DNA by penetratin peptides was first assessed using flow LD to measure the gradual 
decrease in DNA alignment, by monitoring the LD signal at 260 nm as the DNA helix 
becomes condensed upon titration with peptide. Figure 5.15A shows such titrations at both 
low (10 mM NaCl) and physiological (150 mM NaCl) ionic strength in the regime of excess 
DNA (charge ratio r = [+]/[−] < 1). At 10 mM NaCl, all peptides show a similar 
condensation capacity, with a linear dependence on charge ratio and complete elimination 
of DNA alignment at charge ratio r ≈ 0.7. This means that in low salt, the degree of 
condensation is principally dependent on electrostatic interactions between arginine/lysine 
side chains and DNA phosphate groups. By contrast, there is a marked difference in DNA 
condensing capacity at 150 mM NaCl. While PenArg is able to retain its DNA-condensing 
capacity, penetratin and PenLys both display less efficient DNA condensation in presence 
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of 150 mM NaCl. This indicates that whereas arginine interactions with DNA are not 
affected by the electrostatic screening of charges present at higher salt concentration, the 
interactions between lysine and DNA becomes significantly weakened.  
 
Figure 5.15 DNA condensation by penetratin peptides. (A) Condensation in the regime of 
excess DNA, monitored by flow LD at 10 mM NaCl (filled symbols) and 150 mM NaCl (open 
symbols). A small volume of peptide solution was titrated to 100 μM ct-DNA in sodium 
phosphate buffer (pH 7.4) containing 10 mM or 150 mM NaCl. (B) Binding of CF-labelled 
peptides to plasmid DNA in the regime of excess peptide, monitored by quenching of the CF 
emission at 520 nm. Small volumes of 100-300 μM plasmid DNA was titrated to 1 mL 1 μM 
peptide solution in sodium phosphate buffer (pH 7.4) containing 10 mM NaCl (filled symbols) or 
150 mM NaCl (open symbols). (C) Relationship between DNA concentration and charge ratio r. 
The data in (A) and (B) are the mean of 2 or more independent experiments and error bars denote 
the standard deviation between measurements. 
The LD experiment showed that efficient DNA condensation can be obtained already at 
low peptide-to-DNA ratios. However, in transfection experiments it is common to use an 
excess of vector to obtain positively overcharged complexes that could interact more 
readily with the negatively charged cell surface. In the regime of excess peptide (r > 1), 
condensation cannot be monitored by LD, since the DNA is then too condensed to align 
in the flow. Figure 5.15B instead shows the gradual quenching of fluorescein emission, 
when fluorescein-labelled peptides are titrated with increasing amounts of DNA. 
Quenching of the fluorescein peptide label upon complex formation with DNA may be 
explained by self-quenching of proximate fluorescein molecules [196] and we found 
support for this view by observing that quenching was accompanied by absorption 
broadening, indicative of fluorophore-fluorophore interactions. We also verified that the 
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degree of quenching was in qualitative agreement with the extent of peptide binding, by 
separating bound and free peptide fractions by ultracentrifugation. The quenching 
experiments were performed at both 10 mM NaCl and 150 mM NaCl, in analogy with the 
LD experiments. However, since these titrations were done with increasing DNA-to-
peptide charge ratio, the degree of quenching is plotted as a function of inverse charge ratio 
r (i.e. 1/r = cDNA/[+]). For easier comparison between LD and quenching data, 
Figure 5.15C shows how the inverse charge ratio converts to charge ratio. In agreement 
with the LD experiments, the peptides behave similarly at 10 mM NaCl, with quenching 
increasing almost linearly with inverse charge ratio up to 1/r ≈ 0.5, where the emission 
becomes completely quenched. At 150 mM NaCl, we again observe an arginine-dependent 
capacity to interact with DNA. The degree of quenching is in the order PenArg > 
penetratin > PenLys. In addition, the total quenching is considerably less efficient and the 
curves level off before reaching zero, indicating weaker interactions for all three peptides. 
This suggests that significant amounts of free peptide will exist at the point of charge 
neutralization (r = 1). This was not observed in LD, where the total concentrations of 
peptide and DNA were hundredfold higher, thereby shifting the equilibrium towards 
formation of peptiplex. 
Taken together, by studying DNA condensation with two complementary techniques, we 
show that arginines form intrinsically stronger bonds with DNA resulting in more efficient 
peptiplex formation. This can be attributed to that the guanidinium headgroup of arginine 
side chains form bidentate hydrogen bonds with phosphates in the DNA backbone, 
whereas the lysine amine group binds via ionic attraction.  
5.5.2. Stability of Peptide-DNA Complexes 
While the ability to form complexes with DNA may be considered as a first crucial step 
towards non-covalent DNA delivery, the next challenge is for these complexes to remain 
intact and protect DNA in a cellular milieu. The stability of the formed peptiplexes was 
assessed in vitro using two different model systems to mimic cellular environments. First, 
the putative stability of peptiplexes in presence of cellular surfaces was investigated by 
subjecting peptiplexes to heparin. Second, the capacity of the peptides to protect DNA 
from enzymatic degradation was examined.  
Peptiplex stability in presence of heparin was investigated using flow LD to monitor 
decompaction and re-alignment of released DNA. Figure 5.16A shows the change in DNA 
orientation as a function of time after addition of heparin to peptiplexes formed at r = 0.6, 
yielding equimolar charge concentrations of heparin and DNA. Figure 5.16B shows the 
initial (white bars) and final (grey bars) levels of aligned DNA from the kinetic traces. At 
10 mM NaCl, the penetratin peptides all condensed ~75-80% of the available DNA, but 
showed an arginine-dependent behaviour in heparin-induced dissociation with PenArg 
releasing about 60% of the complexed DNA fraction and PenLys showing almost 
complete release. At 150 mM NaCl there is a substantial difference in initial degree of 
DNA compaction, in accord with Figure 5.15, which also means that the starting values 
before dissociation are different. PenArg is again least affected by salt, with equal level of 
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compaction and an even lower level of DNA release (~35% of complexed fraction) than at 
10 mM NaCl. Penetratin and PenLys showed markedly different initial compaction, but 
both released virtually all DNA upon exposure to heparin. This suggests that penetratin 
and PenLys have a much higher relative affinity for heparin compared to DNA and may 
therefore dissociate from the DNA upon encounter with the cell surface. By contrast, a 
substantial fraction of peptiplexes formed with PenArg is resistant to heparin and may 
therefore have a higher probability of remaining intact upon encountering the cell surface. 
In summary, this means that PenLys is insufficient as a DNA delivery vector whereas 
penetratin shows satisfactory DNA condensation but limited stability, and PenArg is able 
to efficiently condense DNA into complexes that also appear sufficiently stable. 
 
Figure 5.16 Stability of peptiplexes in presence of heparin (A) Heparin-induced dissociation 
of peptides from ct-DNA at 10 mM NaCl (solid line) and 150 mM NaCl (dotted line), monitored 
by flow linear dichroism. Peptide was added to ct-DNA (100 μM) at a charge ratio r = 0.6 and 
incubated for 10 minutes before exposure to heparin (100 μM negative charges). The LD signal 
for DNA (at 260 nm) was recorded before and after condensation with peptide, and then 
constantly monitored for at least 20 minutes following the exposure to heparin. (B) Extent of 
DNA condensation obtained with each peptide before and after exposure to heparin, at 10 mM 
NaCl (plain bars) and at 150 mM NaCl (striped bars). The white bars denote the amount of DNA 
orientation remaining after condensation with peptide (i.e. the starting value in the kinetic curves) 
and grey bars denote the final amount of DNA orientation in the sample (i.e. the final value in the 
kinetic curves). Data is representative of two or more independent experiments. 
The ability of the peptides to protect DNA from enzymatic degradation was assessed by 
exposing peptiplexes to serum for 3 h, followed by inactivation of serum nucleases, 
dissociation of complexes with heparin/SDS and analysis by gel electrophoresis. If the 
peptiplexes are sufficiently dense, nucleases will be sterically excluded and the DNA will 
remain intact. Figure 5.17 shows representatives gels and quantification of DNA bands, 
when DNA had been complexed with penetratin peptides at charge ratios from r = 1 to 
r = 10. Whereas uncomplexed DNA was completely degraded under these conditions, the 
penetratin peptides all provided substantial protection with typically 20-30% of the DNA 
remaining fully intact at r = 2 and around 50% at r = 10. In contrast to the heparin 
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dissociation experiments, there are no apparent differences in serum stability between these 
peptides. This suggests that arginines and lysines form complexes of comparable density 
and more generally that high affinity for DNA does not necessarily result in more efficient 
protection. 
 
Figure 5.17 Resistance of peptiplexes towards enzymatic degradation. The stability in 
presence of serum was assessed by gel electrophoresis after dissociation of complexes. Lanes 
represent intact DNA remaining in the samples after condensation with peptides at charge ratios 
r = 1, 2, 5, and 10 from left to right. C: Control samples with intact DNA and with naked DNA 
exposed to serum nucleases, respectively. Data is representative of three or more independent 
experiments. 
The data presented above demonstrate that arginines are superior to lysines in condensing 
DNA into complexes that are stable towards dissociation. However, comparison with the 
two arginine-rich CPPs Tat and R8 (see Table 2.1) that were also investigated in Paper IV, 
clearly shows that a high arginine content is not sufficient to promote DNA binding. 
Instead, both Tat and R8 were found incapable of binding DNA at physiological salt 
concentration in dilute systems, and also dissociated completely from DNA upon 
competition with heparin (see Figure 4 and 6 of Paper IV). By contrast, the most 
hydrophobic peptide studied in Paper IV, transportan (Table 2.1), is also most resistant 
towards heparin, meaning that dissociation in presence of heparin is less efficient when 
peptiplexes are stabilized by hydrophobic interactions (Figure 6 of Paper IV). This suggests 
that in addition to arginines, hydrophobic residues are also required for strong DNA 
binding. PenArg may be a good compromise in this respect, since it in addition to a high 
arginine content also is moderately hydrophobic. Another important difference between 
PenArg and R8/Tat is the spacing of positive charges. This could be important for 
favourable DNA interactions, something that has indeed been observed for 
polyamidoamines [197]. Further support for the importance of hydrophobic residues is 
provided by the fact that the two most hydrophobic CPPs assessed in Paper IV 
(transportan and MPG, see Table 2.1) were superior in terms of DNA protection against 
enzymatic degradation, which clearly demonstrates the need for hydrophobic interactions 
to obtain sufficiently dense complexes, whereas arginine content in this case seems 
insignificant (see Figure 7 of Paper IV). 
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5.5.3. Peptide-Mediated Gene Delivery 
The biophysical data presented above collectively give an indication of the potential of 
these peptides to package DNA so that it can be intactly delivered into cells. Their true 
capacity to do so was also assessed in Paper IV by exposing HEK293T cells to peptiplexes 
prepared by mixing pEGFP-C1 plasmid DNA, encoding enhanced green fluorescent 
protein (eGFP, [179]), with each peptide at charge ratios r = 5 and r = 10, followed by flow 
cytometry analysis to quantify eGFP-expressing cells 24 h later. Transfection was 
performed in presence of endosome-disruptive chloroquine, which eliminates differences 
in transfection efficiency due to differential capacities to escape from endosomes. This 
simplifies comparison of the CPP capacity to mediate uptake of DNA, but rules out the 
influence of events downstream internalization. Figure 5.18 shows the result from these 
experiments, comparing the transfection efficiency of peptiplexes with that of naked DNA 
and the commercially available cationic lipid reagent LipofectamineTM. Whereas PenArg 
transfects ~25-30% of the cells at both charge ratios, penetratin transfects ~20% at r = 10, 
but is not significantly better than naked DNA at r = 5, and PenLys is essentially non-
functional at both charge ratios. The ability to mediate transfection is thus arginine-
dependent and furthermore in qualitative agreement with each peptide’s intrinsic uptake 
propensity as well as its ability to form stable, heparin-resistant complexes with DNA.  
The need for a combination of both efficient uptake and favourable peptide-cargo 
interactions was further confirmed by comparison with other CPPs investigated in 
Paper IV. The arginine-rich R8 and Tat were, despite being associated with efficient 
internalization [36, 55], virtually non-functional as non-covalent DNA vectors, probably 
due to inability to confer peptiplex stability. By contrast, the hydrophobic peptides 
transportan and MPG, which like PenArg combine efficient internalization [30, 33] with 
peptiplex stability, also show high transfection efficiency (see Figure 2 of Paper IV). This 
again supports that arginines are better than lysines, but in the case of DNA condensation 
and delivery, hydrophobic interactions are critical. Indeed, this has been realized also by 
others and chemical modifications aimed to increase hydrophobicity such as stearylation, 
have resulted in enhanced nucleic acid delivery of arginine-rich peptides [122-124]. 
However, our results suggest that a more flexible and versatile approach to enhance 
transfection efficiency of arginine-rich CPPs would be to incorporate hydrophobic amino 
acid residues. Alternatively, one could substitute lysines for arginines in hydrophobic 
peptides such as transportan and MPG. The work presented in this Thesis certainly show 
that the latter approach has been successful for penetratin, and a few other studies have 
also shown improved uptake or transfection with CPPs that have been modified to 
incorporate more arginines [198-201] or guanidinium groups [202]. 
In conclusion, Paper IV clearly demonstrates that arginines are superior to lysines in 
condensing DNA into complexes that are stable towards dissociation in presence of 
sulfated sugars, and this capacity correlates with the ability to mediate uptake and 
expression of plasmid DNA in vitro. In addition to arginines, we also highlight hydrophobic 
residues as key components in stabilizing CPP-DNA interactions. Our results provide 
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mechanistic insights into how different physico-chemical peptide properties contribute to 
successful transfection, with important implications for CPP design. 
 
Figure 5.18 Transfection efficiency of penetratin peptides in HEK293T cells. Plasmid 
pEGFP-C1 was condensed with peptides at charge ratios 5 (light grey) and 10 (dark grey), and 
added to cells in presence of chloroquine. The number of eGFP-expressing cells was assessed by 
flow cytometry 24 hours after transfection. Dead cells were excluded from the analysis via 7-AAD 
staining. Column height represents the average of four independent experiments performed in 
triplicate (N=4, n=3), and error bars represent the SEM. Transfection with negative control 
(naked DNA) and positive control (LipofectamineTM) are shown for reference. Statistically 
significant difference from naked DNA was assessed by a paired Student’s t test; * p < 0.01. 
5.5.4. Improving Gene Delivery with Cysteine 
A potential strategy to improve non-covalent CPP-mediated gene delivery is to enhance 
complex stability by forming peptide multimers. In order to obtain reversible DNA 
condensation, an approach based on addition of cysteine residues has been explored for 
several peptides, including lysine-rich [203] or arginine- rich [204] peptides, Tat [205] and 
the endosomolytic KALA peptide [206]. In addition, transfection with MPG has been 
shown to increase 1000-fold upon addition of a C-terminal cysteamide [61]. This strategy 
enables reversible generation of peptide multimers by formation of disulfide bridges that 
can subsequently be reduced in the intracellular environment and thereby aid DNA release 
[207]. In addition, this approach provides advantages in terms of peptide production, since 
large peptides are expensive and hard to synthesise, and repeated sequences are often 
difficult to express recombinantly [208].  
With the aim to improve penetratin for non-covalent gene delivery, we decided to explore 
the strategy of cysteine addition. To this end, a number of penetratin-based analogs were 
designed by adding a C-terminal cysteine, and efficient, reversible formation of dimers was 
verified by gel electrophoresis (SDS-PAGE), performed under both reducing and non-
reducing conditions (Figure 5.19). Cysteine addition was first assessed for penetratin itself 
and in the presence of endosome-disruptive chloroquine, a C-terminal cysteine improved 
transfection by approximately a factor 2 (Figure 5.20A). The same experiments were 
repeated also in the absence of chloroquine, but cysteine modification did not improve 
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endosomal escape (Figure 5.20B). Addition of cysteine in the N-terminus or in both ends 
(resulting in multimer formation) did not influence transfection efficiency compared to 
C-terminal modification of penetratin (data not shown).  
As a next step, a C-terminal cysteine was added also to PenArg, which had previously been 
shown to be superior compared to penetratin in mediating gene delivery (Figure 5.18). In 
presence of chloroquine, cysteine addition dramatically enhances transfection at r = 2 by 
approximately a factor 6 compared to PenArg (Figure 5.20A). However, with peptide in 
large excess (r = 10), PenArg and PenArg-Cys instead show equal transfection efficiencies, 
indicating that PenArg at this charge ratio is able to form stable peptiplexes even without 
cysteines. As for penetratin, cysteine addition to PenArg did not enhance endosomal 
escape (Figure 5.20B). 
 
Figure 5.19 SDS-PAGE of CPPs. Addition of a C-terminal cysteine results efficient and 
reversible dimer formation in solution.  
Lack of endosomal escape is naturally a severe limitation for delivery of cargo into the cell. 
Therefore, the next step towards optimizing penetratin for gene delivery was to explore the 
penetratin analog EB1 (see Table 2.1), which is N-terminally extended and substituted with 
basic histidines (pKa ~6), in order to yield an amphipathic α-helix upon protonation in the 
acidic endosomal environment. EB1 has previously been shown to be superior compared 
to penetratin in forming complexes and deliver biologically active siRNA into cells [39], but 
has not been used for transport of plasmid DNA. In presence of chloroquine, EB1 was 
able to transfect ~40-50% of the cells, even at a charge ratio of 2 (Figure 5.20A). 
Compared to penetratin and PenArg, EB1 thus shows markedly better transfection 
capacity independent of charge ratio. Addition of a C-terminal cysteine to form EB1-Cys, 
did not improve transfection efficiency further, indicating that with EB1, sufficiently stable 
peptiplexes are formed without cysteines. However, the most striking result was obtained 
in the absence of chloroquine, where the supposedly endosomolytic EB1 peptide was 
unable to mediate transfection, but EB1-Cys transfected a substantial amount of cells 
(Figure 5.20B). By contrast, without chloroquine, the transfection efficiency of EB1-Cys 
was strongly dependent on charge ratio, with less than 5% transfection at r = 2, and ~10% 
at r = 10.  
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In summary, cysteine modification has different effects depending on peptide sequence, 
charge ratio and presence of chloroquine. In the absence of chloroquine, cysteine 
modification improves transfection with penetratin and PenArg at low charge ratios. This 
could be explained by stabilization and enhanced uptake of peptiplexes, but in addition, 
chloroquine has, besides buffering the pH of endocytic vesicles, also been found to induce 
dissociation of vector-DNA complexes [209, 210]. This means that chloroquine could have 
a dual role in enhancing transfection, by improving both endosomal escape and DNA 
unpacking. The fact that PenArg-Cys, EB1 and EB1-Cys all show highest transfection at 
r = 2, with a slight decrease at r = 10, suggests that these peptides form stable complexes 
already at low charge ratios and that a large excess of peptide instead inhibits DNA release. 
In the absence of chloroquine, EB1, which was designed to be endosomolytic, was 
essentially non-functional, while EB1-Cys showed markedly enhanced transfection 
capacity. This points to that whereas EB1 is unable to exert its endosomolytic function 
when bound to plasmid DNA, EB1-Cys more readily interact with the endosome 
membrane and induce endodomal escape. This could be due to an enhanced membrane 
affinity of EB1-Cys dimers, compared to EB1 monomers. Alternative explanations could 
be that EB1 in absence of chloroquine have reduced capacity to dissociate from DNA, or 
that cysteine addition indeed enhances stability and uptake of peptiplexes, but that this was 
not detectable when endosomal escape was induced, due to the large amount of 
peptiplexes that was released into the cytosol. 
 
 
Figure 5.20 Transfection efficiency in HEK293T cells. Plasmid pEGFP-C1 was condensed 
with peptides at charge ratio 2 (light grey) and 5 (dark grey) and added to cells in presence (A) or 
absence (B) of chloroquine. The percentage of cells expressing the transgene eGFP was assessed 
24 h after transfection. Dead cells were excluded from the analysis via 7-AAD staining. Peptiplexes 
were prepared with 0.2 µg DNA per well. The presented data is the mean (± SEM) of at least 3 
independent experiments performed in triplicate. Positive control (LipofectamineTM) yielded 
22±8% in presence and 19±4% in absence of chloroquine. Statistically significant difference from 
naked DNA (dashed line) was assessed by paired Student’s T-test, p < 0.05 (*) and p < 0.01 (**). 
The promising transfection results obtained upon cysteine addition prompted us to further 
investigate the potential of these peptides for gene delivery. Another important aspect is 
that the vector is non-toxic to cells and this was assessed using the LDH leakage assay. 
This assay is based on measurement of lactate dehydrogenase (LDH) activity in the 
A B 
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extracellular medium as LDH leaks out in response to membrane damage [211]. Regardless 
of chloroquine addition, both penetratin and PenArg peptiplexes were virtually non-toxic 
to cells and cysteine addition only shows a slight tendency to enhance PenArg cytotoxicity 
(Figure 5.21). By contrast, EB1 peptiplexes show substantial concentration-dependent 
cytotoxicity, with between ~10-40% leakage upon incubation for 2 h. Importantly, 
EB1-Cys peptiplexes show considerably lower toxicity than the parent peptide EB1, with 
approximately half the amount of leakage. The lower cytotoxic response with EB1-Cys 
could be due to a higher affinity and hence tighter binding to DNA, which would reduce 
the amount of free peptide available for direct interaction with the plasma membrane. In 
summary, this means that by addition of a single cysteine residue to EB1, we have gone 
from a relatively toxic peptide that is trapped inside endosomes, to a peptide that can 
perform endosomal escape and mediate gene delivery in the absence of endodome-
disruptive chemicals, without causing cytotoxic side-effects.  
 
Figure 5.21 Cytotoxicity of peptiplexes. Plasmid pEGFP-C1 was condensed with peptides at 
charge ratio 2 (light grey) and 5 (dark grey) and added to cells. Cytotoxicity was measured by LDH 
release after 2 h exposure to peptiplexes. The presented data is the mean (± SEM) of at least 3 
independent experiments performed in triplicate. Dashed line represent LDH leakage from 
negative control (no peptide added). 
In conclusion, the results from Paper V demonstrate that addition of a single cysteine 
residue to enable peptide dimer formation have the capacity to markedly improve stability, 
enhance endosomal escape and reduce cytotoxicity of peptiplexes. These factors are all 
critical for succesful gene delivery and cysteine modification is therefore a promising 
strategy to improve CPPs as non-covalent delivery vectors. 
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6. CONCLUDING REMARKS 
Cell-penetrating peptides are certainly promising as intracellular delivery vectors due to 
their well-established capacity to enter cells and deliver macromolecular cargos in a non-
toxic manner. Still, there are many challenges on the way towards successful clinical 
application and these include enhancing uptake efficiency, improving endosomal escape 
and targeting specific tissues or cells. In addition, the complex nature of biopharmaceutical 
cargos will most likely require individualized optimization of delivery systems. CPPs are 
adaptable in this way, since the amino acid sequence can easily be modified to obtain new, 
improved peptide functionalities. An alternative approach that might prove most successful 
is to combine CPPs with other delivery agents to obtain multi-component systems that 
combine packaging of cargo, cell targeting, uptake, and endosomal escape. Today, several 
CPP constructs have reached clinical trials, but despite this, we are still striving to 
understand fundamental concepts regarding their uptake and delivery of cargo into cells. 
Therefore, mechanistic in vitro studies that aim at understanding and improving CPP 
function need to be performed in parallel with in vivo studies that continue to evaluate their 
therapeutic potential. Such a dual approach will hopefully make way for CPPs in future 
therapeutic applications. 
This Thesis deals with fundamental concepts regarding the mechanism by which CPPs 
function. Such mechanistic insight is, in addition to being central for development of CPPs, 
also interesting in a broader scientific context, since interactions with and uptake over the 
plasma membrane are fundamental biological processes. The work presented here 
addresses three key steps in the mechanism of CPPs: membrane binding, stimulation of uptake 
and gene delivery, using the classical CPP penetratin as a model peptide. In addition, the 
molecular prerequisites for CPP function are studied, by specifically investigating the 
importance of arginines and lysines in the peptide sequence, and proteoglycans (PGs) on 
the cell surface. A general observation throughout the work of this Thesis is that arginines 
possess characteristics that make them superior to lysines in almost all aspects that are 
important for CPP function. 
Papers I-III explore uptake of penetratin peptides from a mechanistic perspective, by 
comparing uptake efficiency with the corresponding capacity to (1) bind to the cell surface 
and (2) stimulate macropinocytosis. First, in Paper I we show quantitatively that PenArg has 
a greater capacity than PenLys to trigger macropinocytic internalization. In Papers II-III we 
search for explanations for this greater uptake-triggering capacity by quantifying peptide 
binding to the cell surface and find that cell surface affinity is also strongly arginine-
dependent. Moreover, we demonstrate that the amount of peptide that resides at the cell 
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surface is the primary factor that determines penetratin uptake efficiency. This means that 
the greater capacity of arginines to trigger macropinocytosis and internalize into cells first 
and foremost have a pure physico-chemical explanation where the determining factor for 
uptake is the amount of peptide that binds to uptake-triggering sites, rather than specific 
interaction with arginine side chains. Importantly, this means that arginines and lysines can 
promote uptake by the same mechanisms, although arginines more efficiently, due to a 
higher capacity to bind to the cell surface.  
In Paper II, we introduce plasma membrane vesicles (PMVs) as a novel membrane model in 
CPP research. The most important conclusion from this study is that by using a model 
system that is similar to the plasma membrane in both composition and organization, we 
are able to find a direct correlation between membrane interaction and uptake capacity of 
CPPs. This is important, since such correlations have been difficult to find using less 
complex models for the cell surface including lipid membranes or soluble sulfated sugars. 
This clearly demonstrates that cell surface interactions of CPPs are dependent on several 
cell surface groups and their molecular organization at the membrane surface. In addition 
to contributing to our understanding of CPP uptake, this finding will hopefully lead the 
way in development of more cell-like model systems in studies of membrane interactions. 
The role of proteoglycans in uptake of CPPs has been a subject of intense investigation 
during the last decade and this topic was addressed in Paper III. The results from this work 
show that PGs are important for uptake of penetratin peptides, in accord with previous 
observations in the literature. However, since lack of proteoglycans has only a minor effect 
on cell surface binding, the role of PGs in CPP uptake is primarily to trigger internalization, 
not to recruit peptide to the cell surface. By contrast, we demonstrate that the capacity to 
internalize cell surface-associated peptide in absence of proteoglycans is arginine-
dependent, meaning that arginines are less reliant on PGs for internalization and hence 
more versatile than lysines in terms of promoting uptake via multiple pathways. In 
conclusion, the superior uptake efficiency of arginine-rich CPPs can thus be traced back to 
a combination of high cell surface affinity and uptake-triggering capacity. However, we also 
identify one potential drawback with arginine-rich CPPs, and that is the risk of cytotoxicity 
at elevated peptide concentrations. Importantly though, we also find that cell surface 
proteoglycans can reduce this toxic response, which means that these moieties have a dual 
role in CPP-mediated uptake in both promoting internalization and protecting against 
invasive membrane interactions. 
Papers IV-V focus on interactions between CPPs and DNA and the capacity to mediate 
gene delivery using a non-covalent approach. In Paper IV, we explore gene delivery from a 
mechanistic perspective by investigating how the physico-chemical properties of CPPs 
influence their ability to condense DNA into stable peptiplexes that can mediate cell 
transfection in vitro. We demonstrate that arginines are superior to lysines also in this 
respect, but in addition, we find that hydrophobic contributions are needed to stabilize 
peptide-DNA interactions, and are thus decisive for successful gene delivery. Based on 
these results, we suggest substitution of lysines for arginines or introduction of 
hydrophobic residues in existing CPP sequences as a strategy to create novel efficient 
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vectors. The latter would be a more versatile approach than conjugation with hydrophobic 
stearyl or cholesterol derivatives, which has previously been explored for arginine-rich 
CPPs. In Paper V, we investigate an additional strategy to enhance gene delivery, and that is 
incorporation of cysteines into CPPs. We show that addition of a single cysteine residue 
can improve stability, enhance endosomal escape capacity, and reduce cytotoxicity of the 
formed peptiplexes.  
In conclusion, this Thesis identifies several key properties for successful gene delivery with 
CPPs and that is a high arginine content to enhance DNA condensation and promote 
internalization, hydrophobic residues to stabilize peptide-DNA interactions, and a terminal 
cysteine to further improve peptiplex stability and enhance endosomal escape. These 
mechanistic insights provide important implications for design of peptide-based gene 
delivery systems in the future.  
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